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BIOGENIC NANOPARTICLES AND THEIR APPLICATION TO BIOLOGICAL ELECTRON 
 MICROSCOPY 
 
Interest in nanomaterials has seen a dramatic increase over the past twenty years. In recent years 
many have turned toward proteins to aid in developing novel materials due to the mild reaction 
conditions, functionalization, and novel synthetic control of the resulting inorganic structures. Proteins 
have the ability to direct aggregation of inorganic nanostructures, while some enzymes are able to 
perform oxio/reductase activity to synthesize the materials as well. These two general properties are not 
always mutually exclusive and the dual function of certain proteins in nanoparticle synthesis is at the core 
of this work. 
Of all the applications for biogenic nanoparticles, generating tools for biological electron 
microscopy is one of the most appealing. The contrast issue, specifically with in vivo biological sample in 
the electron microscope has drastically limited the information obtainable by this method. An ideal 
biogenic nanoparticle would operate analogously to GFP in optical microscopy and contain the dual 
function characteristics stated above. More specifically it would have to fulfill three criteria: i) reduction 
of a metal precursor, ii) product size control, iii) product retention. To discover such a clonable contrast 
tag we must deepen our understanding of biogenic nanoparticle formation in tandem with discovering and 
developing novel dual function enzymes. 
This work encapsulates both aspects necessary for the development of a successful clonable 
nanoparticle for biological electron microscopy. Current biogenic synthetic methods produce 
nanomaterials with less desirable properties than their inorganic counterparts. Conducting fundamental 
research and establishing a set of rules and guidelines for biogenic methods will ultimately get us closer 
to mimicking the control nature has already developed. 
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This dissertation contains 3 chapters. Chapter 2 focuses on the use of protein crystals as scaffolds 
for nanomaterial synthesis. Herein porous protein crystals were used to control the gold nanocluster 
seeded growth of gold nanorods in an attempt to help establish guidelines for biogenic nucleation 
controlled nanomaterial synthesis. High aspect gold nanorod products were generated from within the 
crystal pores. Subsequent dissolving of the crystals allowed for release of these rods from their template. 
The following two chapters focus on metalloid reductase nanoparticle synthesis in which we have 
discovered and characterized a novel selenophile bacteria. Through purification and mass spectrometry 
we found a glutathione reductase like enzyme to be responsible for Se nanoparticle formation. A 
commercially available glutathione reductase from yeast was used for Se nanoparticle formation in vitro. 
This mechanism was characterized and the system was assessed for potential use as a clonable tag. The 
native enzyme was sequenced and isolated, followed by its own characterization. Our kinetic findings 
suggest this enzyme is the first documented metalloid reductase due to its specificity for selenium 
substrates. The enzymes transportability to foreign organisms demonstrates its potential use as a clonable 
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An Introduction to Protein-Inorganic Materials and Their Application to Biological Electron 
Microscopy  
 Over the past two decades nanomaterial research has found an increasingly broad spectrum of 




 to an array 
of biomedical tools.
7–9
 Current nanomaterials have seen a difficult transfer from academic research to 
industrial application due to synthetic difficulties.
10,11
 Most inorganic nanomaterials require high 
temperatures and harsh reaction conditions and suffer from poor yields. Such reactions are difficult to 
scale up past lab bench quantities. Since nanomaterials exist in a realm between bulk and molecular, small 
changes in their chemical properties tend to have large impacts on their physical characteristics. These 
properties include; chemical composition, crystal structure, size and surface functionality. Unfortunately 
controlling these properties is a major pitfall of nanomaterial fabrication since current methods in doing 




 The 22 unique amino acids which constitute all proteins provide a diverse and unparalleled 
display of functional groups, making polypeptides an enticing biomolecule for nanomaterial development. 
Proteins generally consist of hundreds of amino acids leading to a seemingly endless amount of chemical 
compositions and properties. For example a protein made from 100 amino acids would have 22
100
 unique 
amino acid combinations. Proteins can further alter their chemical composition through post-translation 
modifications of which over 200 are known.
12
 Such a vast potential chemical space allows proteins high 
binding specificity and reactivity, all of which are applicable to metals. Just because proteins have a large 
potential chemical composition available to them does not mean they are all easily accessible. Fortunately 
evolution has provided us with a plethora of interesting proteins for nanomaterial development, and we 
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 and directed evolution.
15
 
 The idea to apply proteins to inorganic materials can be attributed to earlier research on 
biomineralization. Research on sea based organisms allowed critical breakthroughs in our understanding 
of the role that proteins can play in directing biomineralization of inorganic structures. More specifically 
species which possessed the ability to form SiO2 structures at ambient conditions.
16
 The most popular 
type of organisms studied are diatoms, a unicellular algae which produce cell walls composed of silica.
17
 
These organisms have developed the ability to not only conduct biomineralization in mild conditions but 
form extremely intricate designs from the nanoscale to microscale (Figure 1.1). It also became apparent 
that these networks were genetically controlled since the patterns and structural details was species 
specific.
18
 Further studies uncovered the biomolecules responsible from biosilification consisted of long-
chain polyamines (LCPAs) and proteins (silaffins and silacidins).
19,20
 The discovery of these 
biomineralization pathways sparked interest in applying such avenues to inorganic material formation and 
an array of metal oxides were successfully templated.
21–23
 
Figure 1.1. SEM images of cleaned diatom silica cell walls (frustules) from several different diatom 





 Proteins isolated from sea organisms initiated the research which evolved into the bio-
nanomaterial field we know today, but a myriad of other proteins have been used in material fabrication. 
Proteins used in such system can serve two overarching functions, (i) templating or (ii) nanostructure 
synthesis. It should be noted that while it is clarifying to categorize these functions, they are not always 
exclusive. Templating, or biomineralization, involves the directed aggregation of metal precursors or the 
reduction of promiscuous salts followed by directed aggregation. Such methods can direct growth of 
nanostructures leading to more control during synthesis and generating more predictable properties as 
seen in Figure 1.2.  
Figure 1.2. TEM images of Cu nanocrystals biomineralized on nanotubes displaying HG12 peptide at pH 
6 (a) pH 8 (b) and without HG12 (c).
25
 
Nucleation of gold nanoparticles has been controlled in this manner using lysozyme crystals,
26
 by 
restricting gold nanoparticle growth to the crystal pores. Following a similar technique collagen can be 
formed into fibers structures in vitro and has successfully templated mesoporus alumina,
27





 Multimer viral capsids are responsible for transporting and protecting viral genomic 
material. These hollow protein systems have been used to direct nanoparticle formation on their surface 
with Pt, Ag, and Au.
29,30
 Size control of inorganic nanostructures has been demonstrated with many 
systems and compositions. For example addition of the polypeptide pytochelatin as a surface passivating 
agent improved monodispersity in CdS quantum dot synthesis,
31
 small modifications to a templating 
peptide altered gold sphere diameters,
32
 and  tuning peptide conformation conveyed size control over Cu 
nanocrystals.
25
 Outside of size control crystal packing can be influenced by their templates due to the 
binding residues preference for certain crystal facets.
33
 
Proteins that provide synthetic components for nanostructure formation tend to involve an 
oxio/reductase active site. Nature has provided many examples of this surrounding in vivo iron usage. 
Ferritin and DPS proteins moderate iron levels through enzymatic ferroxidase centers.
34,35
 While a host of 
proteins in magnetotatic bacteria are involved in magnetosome moderation through redox sites.
36
 The 
silicateins identified from sea sponges were found to use an active site serine to catalyst the formation of 
silica,
37
 which was more recently shown to also be responsible for TiO2 formation.
38
 Outside of these 
native functioning natural proteins the pyridine nucleoside dependent oxioreductases have also shown the 
ability to enzymatically generate inorganic nanoparticles. The most notably of these enzymes is mercuric 
reductase,
39
 but also includes glutathione reductase, nitrate reductase, and thiodoxin reductase to name a 
few. This family of enzymes has shown the ability to form a collection of inorganic nanoparticles outside 
of their designed function.
40–43
 These secondary functions have provided an alternate route for catalytic 
nanomaterial generation.  
As stated before proteins involved in these nanomaterial systems have the ability to both 
generated reactive components, and act as a template for the nanomaterial. Enzymes with this dual 
function provide an alluring starting point for potential applications such as bio-imaging, and more 
specifically biological electron microscopy. Biological electron microscopy suffers from what is 
commonly known as the contrast issue. Electron microscopy (EM) methods generate images based on the 
samples interactions with the electron beam. As your sample increases in atomic weight the more it will 
5 
 
interact with the beam. Unfortunately biological samples are all made of the same “light” elements and all 
details are completely lost. Such low sample signal can be overcome by extended measurement times or 
increased beam intensity, but beam damage to biological samples happens almost immediately with 15 to 
40% of sample massing being lost in the first 30 seconds.
44
 This lack of contrast limited results from 
biological EM to only resolving cellular super structures such as cell walls. More recent advancements in 
cryo sample preparation has increased biological sample stability.
45
 This, paired with technological 
advancements, has drastically increased the efficacy of biological EM. This is clearly seen with the 
explosion of the single particle cryo EM field. Such techniques have been used to solve thousands of 
biological structures in vitro.
46
 Even with all of the recent advancements, the field is still limited to 
resolving in vitro samples. To this day the contrast issue still plagues in vivo samples.
47
  
Over the years a large effort has been put toward solving this issue with limited success. Heavy 
metal staining is a common practice to help elucidate major ultrastructures but has limited specificity 
(Figure 1.3).
48
 Another common technique was developed using gold labeled antibodies. This is known as 
immunolabeling and has shown success in the literature for a range of proteins.
49–51
 Unfortunately there 










Figure 1.3. Thin section of Mycobacterium Jucho strain stained with osmium tetroxide, fixed and treated 
with unranyl-acetate, and embedded in araldite. The cell wall (CW), cytoplasmic membrane (CM), 
polyphosphate granuale (P), and nuclear apparatus (N) are highlited.
48
 
A proposed improvement to these techniques and a solution to the contrast issue as a whole 
would involve an in situ clonable tag analogous to the green fluorescent protein (GFP) used in optical 
microscopy. Various polypeptides have been assessed for this task including ferritin, metallothionein, and 
proteins from magnetotatic bacteria. Ferritin has shown some success as a clonable tag,
34
 but only 
functions as a 24mer totaling around .45 MDa which has severely limited its usefulness.
53
 Metallothionein 
requires stoichiometric amounts of gold salts which again lead to a very large tag and high background 
noise.
54
 Studies have shown that genes from magnetotatic bacteria must work synergistically to form iron 
oxide particles and membrane encapsulation is inevitable with products averaging 100 nm.
55
 It is apparent 
that all of the current in situ clonable tags are much too large to be successful in biological EM.  
Such a tag must fulfill 3 main requirements: i) reduction of a metal precursor, ii) product size 
control, iii) product retention. All assessed systems to this point have failed at least one of these criteria. 
Collectively these specifications are the culmination of the current protein-nanomaterial field. The ideal 






Figure 1.4. Schematic for an ideal clonable tag for biological electron microscopy. 
At its current state, the biogenic nanomaterial field has provided alternative synthesis strategies 
for nanomaterials under mild conditions which could eventually be scaled to an industrial setting.
10
 But at 
this time strictly inorganic routes allow for increased synthetic control leading to higher quality products 
with more desirable properties than their biogenic counterparts. Proteins provide an unprecedented 
chemical space which can supply endless surface functionalities and 3D structures, while providing 
tunable specificity and reactivity. Synthetic control of any regime of nano science remains a challenge 
and the current methodologies regarding protein-inorganic hybrids are severely limited. Furthering our 
understanding of how proteins manipulate nanostructure formation is crucial for the development of 
nanoscale applications. With minor alterations at the atomic level causing such major transformations on 
the macro scale our control must be more precise than ever before. A deepened understating of this field 
may provide a solution to the underlying problems with biological electron microscopy. There have been 
many attempts to solve the contrast issue but it is apparent that our lack of control in biogenic 
nanoparticle formation is limiting our success. Apart from furthering our understanding of biogenic 
controlled nanoparticle formation we must also search for novel proteins which can fulfill the three 
criteria necessary for a functioning clonable nanoparticle. A successful clonable tag will most likely be 
derived from a naturally occurring protein. Thus we must begin to understand what makes a polypeptide 
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 Precise and programmable bottom-up synthesis of inorganic nanoparticles represents a grand 
challenge of inorganic materials synthesis. Such structures applied to nanomedicine, electronics, 
photonics, imaging, and sensing. Here we show that a protein crystal can serve as a scaffold to direct the 
growth of high aspect ratio gold nanorods. Nanorod growth is further controlled by the presence of pre-
defined nucleation points within the crystal. The resulting structures can be released from the protein 
matrix. 
2.2 Introduction 
A grand challenge in inorganic nanoparticle synthesis is the production of asymmetric 3D 
nanoparticles.
1
 These particles have many applications in sensors, solar cells, biological imaging, 
electronics, energy storage devices, and cancer therapies.
2–7
 High-aspect ratio nanorods and other low-
symmetry particles attract interest for their anisotropic optical properties.
7,8
 However, these particles are 
more difficult to synthesize homogenously, economically, and in bulk.
9
 Solution phase synthesis can 
produce a variety of nanoparticle shapes
10
 and nanorods with aspect ratios up to ~50.
11,12
 Still, solution 
phase synthesis often requires trial and error searches for reaction conditions that produce the desired 
nanoparticle shape, and product polydispersity is a challenge.
13–15
 Lithographic approaches can fabricate 
arbitrary shapes in 2D and in a limited way in 3D, but ‘top-down’ approaches are limited in the quantity 
of material that can be produced when compared to ‘bottom-up’ approaches.
16,17
  
                                                          
*
The work presented herein is to be published in ACS NANO. Richard S. Nemeth’s contributions to this 
work include experimental design, data analysis, synthetic development and characterization of gold 
nanorods used in this study. 
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Templated synthesis is a promising approach to retain more control over nanoparticle shapes in 
three dimensions. Proteins in particular are an attractive template for the growth and placement of 
nanoparticles.
18,19
 Recently researchers have synthesized nanoparticles within a variety of scaffolds. For 
example, several groups have grown gold nanoparticles within lysozyme crystals
20–22
, while others have 
used viruses
23
 and functionalized protein cages
24–26
 to produce a variety of nanostructures.
27
 As 
researchers gain the ability to control protein assembly topology,
28–31
 limitless programmed or designed 
template morphologies can be imagined. Protein crystals can be highly solvent accessible and contain 
hundreds of millions of identical pores, allowing for extremely parallel growth of anisotropic 
nanostructures. 
Here we show that protein crystals can serve as scaffolds to grow high aspect ratio gold nanorods. 
We have previously immobilized 25-atom gold clusters within the pores of a protein crystal.
32
 Now, these 
clusters serve as nucleation sites for the controlled growth of gold nanorods. We show that, under certain 
conditions, growth can be dependent on the presence of seeds, and that the method can be expanded to 
other scaffolds. By nucleating growth on pre-defined seeds, we separate nucleation and growth, allowing 
greater control over the growth of metal nanostructures. 
2.3 Results and Discussion 
The scaffold protein crystal was selected in a systematic, automated screen of the Protein Data 
Bank for protein crystals with large solvent channels. The crystal selected from the database is composed 
of a single protein, CJ0 (Fig. 1) (Genebank ID: cj0420, Protein Data Bank code: 2fgs). CJ0 is a putative 
periplasmic polyisoprenoid-binding protein from Campylobacter jejuni. The vector encoding CJ0 was 
obtained from the Protein Structure Initiative’s Biology-Materials Repository. 
The protein was expressed and purified as described previously.
32
 Crystals were grown in 
ammonium sulfate buffer at pH 6.5 and subsequently crosslinked by direct addition of 100 mM 1-Ethyl-
3- (3-dimethylaminopropyl) carbodiimide (EDC) and 50 mM imidazole. The crosslinking reaction was 
quenched after 1 hour via addition of 50 mM sodium borate at pH 10.0. 
14 
 
Figure 2.1. (a) Top-view Pymol schematic of several unit cells of CJ protein crystal, showing ~13 nm 
diameter cylindrical pores. (b) Solvent channels (Chapter 5.1.36- 5.1.37). (c) TEM micrograph of a thin 
section of a CJ crystal reveals repeating axial pore structure depicted in (a). Inset: FFT-simulated image 
obtained from the micrograph in (c). 
 
Crosslinked CJ crystals absorb Au25 clusters with glutathione and nitrilotriacetic acid ligands 
(Au25(GSH)17(NTA)) by a shared affinity for Ni(II) between the NTA and scaffold Histidine tag, as 
described previously.
32
 These gold clusters then serve as nucleation sites for controlled gold growth once 
the crystal is placed in a growth solution consisting of polyvinylpyrrolidone (PVP), potassium iodide 
(KI), chloroauric acid (HAuCl4), and ascorbic acid. As previously shown,
33
 KI and PVP can act as 
coordinating and capping ligands, respectively. PVP and KI limit the auto-nucleation of particles, a well-
known issue for HAuCl4 in the presence of protein.
34,35
 Growth occurs over 10 minutes (Fig. 2).  
15 
 
Figure 2.2. CJ crystals with (i) and without (ii)  Au25(GSH)17NTA seeds, in the gold growth solution 
consisting of PVP, KI, HAuCl4, and ascorbic acid at (a) t = 0 and (b) t = 10 mins. Scale bar is 100 um. 
 
The resulting gold structures could be released from crystals for downstream applications and 
analysis. Crystals were dissolved in 0.5 M NaOH at 35
o
C overnight (Chapter 5.1). Transmission electron 
microscopy (TEM) images of the dissolved crystals from Figure 2.1 show the gold structures present in 
the sample (Chapter 5.1.14). 
Gold growth also occurred within the crystals using a variety of alternative gold precursors and 
reducing agents (Chapter 5.1.1-5.1.13 and Chapter 5.1.16). The protocol that resulted in synthesis (and 
recovery) of the highest aspect ratio gold nanorods, shown in Fig. 3, was to soak seeded crystals in 10 
mM HAuCl4 for 10 mins, then transfer the crystals to a drop of 10 mM ascorbic acid for 1 hr, at which 
point the crystals were black by eye (Figure 5.1.1). Notably, this protocol did not require the presence of 
seed particles; the high reduction potential of HAuCl4 causes self-nucleation, aided by ascorbic acid and 
the reducing amino acids in the crystal.
36–38
 However, we determined by TEM and elemental analysis that 
allowing gold nanoparticle seeds to adsorb within the crystal before growing the rods led to significantly 
higher overall growth within the pores (~700 versus ~200 gold atoms per unit cell of the crystal, as 
determined by ICP-MS elemental analysis). Still, with the seeded growth method, elemental analysis 





Figure 2.3.  TEM of representative gold structures from seeded CJ crystals when grown in 10 mM 
HAuCl4 for 10 mins, transferred to a drop of 10 mM ascorbic acid for 1 hr, and then dissolved. Scale bars 
are 100 nm. See Chapter 5.1.1-5.1.16 for additional examples of structures resulting from this and 
alternative growth methods. 
 
To further demonstrate scaffold-limited gold growth, we recapitulated crystal growth experiments 
using a pyridine nucleotide-disulfide family oxidoreductase from E. faecalis (PDB entry 3oc4). These 
later crystals have 5 and 9 nm cylindrical pores (Figure 5.1.20). 
To confirm growth occurred within the crystal, we attempted to image the gold structures while 
still encapsulated within the protein (Chapter 5.1.30-5.1.32). Figure 2.4 suggests gold structures 
embedded within partially dissolved or crushed 3oc4 and CJ crystals. In Figure 2.4 (a) and (c) we see 
parallel streaks of high electron density embedded within a lower electron density matrix indicative of the 
presence of anisotropic gold structures within partially dissolved crystals. In Figure 2.4 (b), the arrow 
indicates a 20 nm diameter nanorod of high electron density, which has been sheared radially at the 
exposed end, potentially during the liquid N2 freezing and crushing process. 
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Figure 2.4. TEM of in situ rods embedded within (a) partially dissolved CJ crystals, (b) liquid N2 
shattered CJ crystals and (c) partially dissolved 3oc4 crystals. Top scale bars are 100 nm. 
 
Somewhat surprisingly, typical nanorods (Fig. 3) grown within CJ crystals had an average 
diameter of 20.2 ± 4.7 nm. The maximum length of rods recovered from dissolved crystals was 870 nm 
(Chapter 5.1.21-5.1.23). Rods from 3oc4 crystals were typically ~5nm in diameter. We hypothesize that 
typical rods were slightly larger in diameter than the pores of the crystal, because the protein could be 
displaced outward during rod growth (Chapter 5.1.21-5.1.23). 
Rods released from crystals were further analyzed by high-resolution transmission electron 
microscopy and by 3-D electron tomography. High-resolution electron microscopy revealed atomic 
columns of Au within the nanorods, as well as the size, shape and orientation of crystallites within the 
nanorods (Fig. 5). Systematic analysis of the crystallite size, orientation and periodicity within rods did 
not reveal any clear patterns.  For instance, we did not observe periodicity conforming to the 5 nm height 
of the crystal unit-cell or lattices that may extend the icosahedral core of the seed particles. Electron 
18 
 
diffraction (Fig. 5) revealed only the presence of fcc (bulk-phase) Au. Lack of extended periodic patterns 
within the rods (seen in the electron diffraction data in Fig. 5) is in accord with these results. 
Figure 2.5. HR-TEM of gold nanorod released from CJ crystal scaffold. Scale bar is 25 nm. 
 
 
 We observed in some cases discrete rods and in other cases bundles of rods. In cases where we 
observe bundles of rods, the rods appeared to be connected by short bridging segments.  These may arise 
from the smaller lateral solvent channels in the crystals.  We collected tilt-series of rod bundles to produce 
tomographic reconstructions assembled in IMOD / 3DEM
39
 to generate 3D models of the rod bundles 
(Fig. 6, Fig. 5.1.29). The 3-D models confirmed that the observed rod interconnects between rods arose 
from lateral junctions consistent with the lateral solvent channels found in the template crystal (Fig. 1b), 







Figure 2.6. (a) Tomographic reconstruction of nanorod bundle resulting from dissolved CJ crystals. (c) 
Electron diffraction heat map crystallographic orientation analysis of (b), HAADF STEM of rods released 
from CJ crystal. Red, blue, and green in (c) correspond to 3 distinct crystal orientations. Other crystal 
orientations were not included in the analysis and will correspond to black space in (c). 
 
2.4 Conclusions 
 By growing gold nanorods on pre-defined nuclei, we were able to separate nucleation and growth 
steps of nanorod synthesis.  Seeded growth facilitated the synthesis of high aspect ratio gold nanorods 
within protein crystal molds. Such crystals provide a designable matrix for the synthesis of guest 
nanomaterials. We identified conditions such that the growth of rods depended on the presence of a seed 
and the resulting shape depended on the crystal scaffold used. Furthermore, the surrounding scaffold 
could be dissolved, releasing the rods for downstream use. This is a promising new paradigm for the 
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Pseudomonas moraviensis stanleyae was recently isolated from the roots of the Selenium (Se) 
hyperaccumulator plant Stanleya pinnata. This bacterium tolerates normally lethal concentrations of 
SeO3
2- 
(selenite) in liquid culture, where it also produces Se nanoparticles. Structure and cellular 
ultrastructure of the Se nanoparticles as determined by cellular electron tomography shows the 
nanoparticles as intracellular, of narrow dispersity, symmetrically irregular and without any observable 
membrane or structured protein shell. Protein mass spectrometry of a fractionated soluble cytosolic 
material with selenite reducing capability identified nitrite reductase and glutathione reductase 
homologues as NADPH dependent candidate enzymes for the reduction of selenite to zerovalent Se 
nanoparticles. In vitro experiments with commercially sourced glutathione reductase revealed that the 
enzyme can reduce SeO3
2-
 to Se nanoparticles in an NADPH- dependent process. The disappearance of 
the enzyme as determined by protein assay during nanoparticle formation suggests that glutathione 
reductase is associated with or possibly entombed in the nanoparticles whose formation it catalyzes. 
Chemically dissolving the nanoparticles releases the enzyme. The size of the nanoparticles varies with 
SeO3
2-
 concentration, varying in size form 5nm diameter when formed at 1.0 μM [SeO3
2-
] to 50nm 
maximum diameter when formed at 100 μM [SeO3
2-
]. In aggregate, we suggest that glutathione reductase 
possesses the key attributes of a clonable nanoparticle system: ion reduction, nanoparticle retention and 
size control of the nanoparticle at the enzyme site. 
                                                          
*The work presented herein is published in Nanoscale. Richard S. Nemeth’s contributions to this work 
include experimental design, data analysis, synthetic development and characterization of enzymatically 






A grand challenge in biogenic inorganic nanoparticle synthesis is a clonable nanoparticle. That 
is, specifically, a single clonable polypeptide sequence that mediates the self-contained formation of an 
inorganic nanoparticle from inorganic salt precursors.  Just as the clonable fluorophore, green fluorescent 
protein (GFP), is widely used for clonable contrast in biological optical microscopies,
1
 a clonable 
inorganic and electron-dense nanoparticle is expected to find widespread use for cellular contrast in 
biological electron microscopy.  In each case facile genetic methods for concatenating DNA encoding a 
protein sequence to the DNA sequence of a native cellular protein underlie the utility of clonable 
microscopy contrast.  Expression of the resulting chimeric protein places a contrast marker alongside 
every instance of the native protein, enabling localization of the protein chimera in micrographs.  
A clonable nanoparticle requires a polypeptide that integrates three distinct chemical activities.  
One activity is inorganic ion reduction or oxidation, converting soluble (ideally bioavailable and 
nontoxic) inorganic ions to insoluble (nanoparticulate) species.  Second, the resulting inorganic 
nanoparticle must be retained by the polypeptide.  Third, the size of the resulting nanoparticle must be 
large enough to identify unambiguously in a micrograph that includes biological structure, while also 
being small enough to minimize perturbation of cell biology and to reduce the shadow-casting that 
obscures biological information.  An ideal size is suggested as 5 nm diameter.  So far, there is no widely 
adopted clonable contrast marker in biological electron microscopy. 
Both naturally occurring proteins as well as peptides isolated from libraries are investigated as 
candidate clonable nanoparticles.  Naturally occurring proteins investigated include most prominently 
ferritin and metallothionein.  In the case of the iron-storage capsule protein ferritin,
2
 the requirement of 24 
subunits with a total mass of nearly 0.45 MDa
3
 may limit its use. Metallothionein coordination of Au(I) or 
Au(III) based ions is also proposed,
4–6
 but these methods are not widely adopted in biological electron 
microscopy. This is perhaps because the Au(I) precursors are sparingly soluble in water and Au(III)-based 
25 
 




 and other biomolecules 
encountered in a cellular environment.
12–15
 
Proteins associated with magnetosomes such as mms6 are also initially attractive for forming 
clonable iron oxides.
16
  However, a recent study shows that cloning of a minimal set of magnetosome-
associated genes into a new host cell results in membrane-encapsulated iron oxide nanoparticles.
17
 Such a 
membrane would clearly disrupt the function of a clonable nanoparticle, by adding size and possibly 
membrane sequestering proteins tagged for study. 
Another investigated source of a polypeptide satisfying the clonable nanoparticle criteria is 







 that mediate inorganic nanoparticle formation.  In fact, early reports suggested that some 
library-derived peptides possessed the three desired activities of reduction, retention and size control.
23,26
 
Subsequent studies revealed that the buffers such as HEPES
11
 or other Good’s Buffers,
10 
 in which the 
selections were executed, reduced the inorganic precursors.
27 
The role of the evolved biomolecules is to 
cap the nanoparticles resulting from buffer reduction of metal ions, enforcing size and shape control.  One 
of the best studied systems, the A3 peptide,
26,28–31 
 shows a  preference for a size where the radius of 
curvature of the nanoparticle matches the curvature naturally adopted by the peptide.
28
 Thus, while 
inorganic nanoparticle binding (retention) and size control are now well-established for peptides and 
polynucleotides, there are no well-established examples of peptides that catalytically or stoichiometrically 
reduce metal ions for the production of particles large enough to find use in biological electron 
microscopy. 
Enzymes that reduce or oxidize metal ions into insoluble forms represent another class of 
biomolecule candidate for a clonable nanoparticle, and are the least extensively investigated.  Such 
enzymes include silicateins,
32,33 







reductases implicated in detoxification processes. Resulting nanoparticle size is regulated when the 




 Alternatively, enzymes release 
or turn over their products, allowing them to diffuse from the site of synthesis.
34,41 
  Notably, there are no 
26 
 
well-established examples of intracellular particles wherein the inorganic portion of the particle is 
exposed to cytosol. 
In the present work, we investigate the formation, enzymology, structure, and cellular 
ultrastructure of biogenic selenium nanoparticles (SeNPs) made by a strain of Pseudomonas fluoroscens, 
P.moraviensis Stanleyae, recently isolated from a seleniferous environment, inside Se hyperaccumulator 
plant Stanleyae pinnata. While Se is an essential element for many organisms, the range between 
essentiality and toxicity is very narrow.
42





, (selenate) to zerovalent SeNPs by selenospecialist bacteria has be previously 
established.
38,39,43,44
 Depending on the species, the resulting SeNPs may be extra- or intra-cellular.
45
 
Enzymes including nitrite reductase are identified by proteomic mass spectroscopy on purified 
nanoparticles or in fractionated cell extracts assayed for Se oxyanion reductase activity.
37-39
 Very little is 
known about the mechanism of particle synthesis, the relationship between enzymes that synthesize the 
nanoparticles and the nanoparticles, and the physical interface between nanoparticles and the cytosol. For 
instance, most intracellular nanoparticles are coated by a membrane or a structured protein coat. There is 
also little investigation of the means of size control for biogenic and/or enzymatically produced Se 
nanoparticles. 
In the present work, we report the first 3D electron tomographic reconstruction of cells containing 
SeNPs, and infer unprecedented aspects of the nanoparticle and nanoparticle/cytosol interface that may be 
unique to SeNPs, and especially relevant for the application of SeNPs as clonable nanoparticles. We show 
the possibility of size control of the nanoparticles, and show that a large fraction of enzymesare physically 
associated with nanoparticles. Overall, our results present the first report of a polypeptide that possesses 
the three coincident activities required for a clonable nanoparticle useful in cellular electron microscopy: 






 In order to further investigate other clonable biomolecules that may be capable of forming 
inorganic nanoparticles we turned to an endophyte brought to our attention by a visiting scholar. 
Pseudomonas moraviensis stanleyae was isolated from the roots of Stanleya pinnata, a Se 
hyperaccumulator plant native to western USA,
46
 and observed to tolerate unusually high concentrations 
of SeO3
2-
. When grown in Luria Broth supplemented with 10 mM Na2SeO3, the cultures become notably 
pink in color during early log-phase. This color change (Figure 3.1) is associated with the formation of 
zerovalent (red) Se. The conversion of selenite oxyanions to zerovalent Se is a common detoxification 
process for bacteria that tolerate high concentrations of Se oxyanions.
47 
Figure 3.1. Photographs of P. moraviensis stanleyae liquid LB cultures. The culture on the left is 
supplemented with 10 mM SeO3
2-
. Upon initial growth, both cultures appear as the no-selenite control 
culture shown on the right. We attribute the red color of the culture, to which selenite is added, to the 
reduction of selenite and zerovalent red selenium. 
Initial characterization of the SeNPs produced by P. moraviensis stanleyae was performed by 
transmission electron microscopy (TEM), scanning electron microscopy (SEM) with energy dispersive X-
ray spectroscopy (EDS) elemental mapping, and 3-D cellular electron tomography. 
28 
 
An initial TEM examination of glutaraldehyde-fixed concentrated cell culture of P. moraviensis 
stanleyae, dry mounted on a carbon-coated TEM grid (Figure 3.2, panel A) revealed relatively uniform 
(107 ± 35 nm) high-contrast circular morphology spots both inside (or superimposed on) and outside of 
the bacterial cells. Scanning transmission electron microscopy of the same sampled allowed EDS 
mapping of elemental composition. The EDS mapping confirms that the high-contrast spots are Se-rich.  
(Figure 3.2, panel B)  This suggests that the high-contrast spots are Se nanoparticles that account for the 
red color of the bacterial cultures.  Similar spots were not observed in control cultures that were not 
supplemented with SeO3
2-
.  At least 50 were examined in the control observation, high density spots were 
observed only with one cell, and in that instance the morphology was notably irregular compared to the 
putative SeNPs (Figure 3.3). 
 Figure 3.2. Transmission electron micrographs of glutaraldehyde-fixed dry mounted cells are shown in 
panel A. Electron-dense (dark) inclusions are present in many of the cells in panel A, as well as outside 
the cells. Panel B shows a scanning transmission micrograph of a selected area of one of the cells that 
includes a dark inclusion; overlaid on this inclusion is an EDS map of Se in the sample, indicating that the 
inclusion is Se-rich. Panel C shows a histogram of observed particle sizes. 
29 
 
Figure 3.3. Representative micrographs showing irregular electron dense object. 
Dry mount electron microscopy provides comparatively limited information compared to more 
sophisticated preservation and imaging methods, such as cellular electron tomogrpahy.
48,49
  With 
appropriate preservation,
50-52
 these methods allow high fidelity 3D resolution of cellular ultrastructure 
such as membranes and major cytoskeletal filaments, organelles and ribosomes.
53
 Here we used electron 
tomography to definitively reveal whether the observed nanoparticles are inside the cells (as opposed to 
superimposed), reveal membranes, and reveal major cellular ultrastructure.  P. moraviensis Stanleyae 
cells were grown as described in the methods section, both with and without 10 mM SeO3
2-
 
supplementation into the stationary phase where particles are easily discernable.  Concentrated cultures 
were subjected to freeze substitution,
50
 which provides the highest fidelity preservation of cellular 
ultrastructure aside from vitrification.
54
 Vitrification was not used here because the size of the cells would 
require cryo-sectioning, which is technically difficult and not routinely successful. 
3D reconstructions of both unstained and osmium stained 200 nm sections revealed large 
inclusions inside the cells. In the case of metal-stained cells, it was unclear whether the inclusions could 
be attributed to the staining of biological material or to SeNPs, although other ultrastructures (such as 
both inner and outer membranes) were clearly revealed (Figure 3.4). 
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Figure 3.4. Electron tomographic reconstruction of P. moraviensisi stanleyae with osmium staining. The 
outer membrane (green) , inner membrane (yellow) and putative SeNP (pink) densities are segmented. 
Due to the presence of stain, the particle segmentation is ambiguous. 
The reconstructions of unstained cells were more informative.  Figure 3.5 shows a segmented 
reconstruction of a single cell; the outer membrane was segmented by hand, as is current standard practice 
with IMOD, while the SeNPs were sufficiently electron dense that segmentation could be accomplished 
automatically with a simple thresholding operation. Imodauto was set at a threshold of 1 (out of 255), 
which generated a model. This clearly auto-segments out high-density inclusions that we attributed to 
SeNPs.  In each of three 3D reconstructions of cells grown with SeO3
2-
 supplementation we observed 
high-contrast inclusions of 58.66 ± 2.47 nm diameter (from a total of 3 particles observed). 
Figure 3.5 shows a 3D segmentation of one of the cells, with a XY view shown in panel B and an 
YZ view shown in panel C.   These two views reveal unambiguously for the first time that large SeNPs 
can be intracellularly contained, where previous studies were 2D microscopy and could not rule out that 
particles and cells are superimposed.  Notably, there is no evidence that these particles are membrane-






Figure 3.5. Electron tomographic reconstruction of P. moraviensis stanleyae. The reconstruction was 
segmented to reveal the outer membrane and SeNP nanoparticles (panels A-C). Magnified views of two 
SeNPs are show in panels D and E; panel D shows the large SeNP in the middle of the cell in panel B. 
Panel E shows the large SeNP in the upper left part of the cell in panel B.  
Panels D and E of Figure 3.5 show the three larger intracellular particles at greater magnification.   
From these images it appears that while the particles are “approximately spherical” they are not perfectly 
spherical and in fact are symmetrically irregular.  Some of the irregularity in these images is artifact.  The 
“spikiness / texture” of the surface is also observed for the 10 nm diameter gold nanoparticles used as 
fiducial markers for alignment.
52
  The anisotropic ‘speckling’ halo that surrounds some of the particles 
likely arises from the ‘missing wedge’ artifact in electron tomography.
56
  Even accounting for these 
sources of artifact, however, the nanoparticles appear symmetrically irregular. 
To derive greater insight into the mechanism of formation of these SeNPs, we identified proteins 
implicated in the reduction of SeO3
2-
 to Se(0) by P. moraviensis stanleyae.  Briefly we fractionated the 
soluble proteins from cell lysate on a nondenaturing polyacrylamide gel, and then stained the gel with 
metalloid oxyanions and electron donating cofactors.  Any resulting bands indicating the presence of 




To obtain better resolution, cell lysate of P. moraviensis Stanleyae grown in SeO3
2-
-supplemented 
media was further fractionated on a hydrophobic interaction column (HIC) that was eluted with different 
concentrations of (NH4)2SO4. Proteins in each fraction from the HIC column were separated on a non-
denaturing polyacrylamide gel.  To develop bands corresponding to selenite reductases, gels were placed 
into nitrogen-filled zip-lock bags filled with a buffer supplemented with metalloid oxyanions and 
NADPH or NADH. The entire protocol was adapted from previous work by Hunter.
38
 
Figure 3.6 shows the results of this experiment for the reduction of SeO3
2-
 in the presence of 
NADPH. Clearly there are proteins with selenite reductase activity present in some of the HIC fractions. 
Tellurite (TeO3
2-
) reductase activity was observed with similar gel mobility, although the bands were less 
intense.   No notable reduction of selenate or tellurate (TeO4
2-





 was notably weaker when NADH instead of NADPH was used as an 
electron donor. No bands developed in the absence of NADH or NADPH. 
Figure 3.6. Native gel of HIC column fractions, stained with SeO3
2-
 and NADPH to reveal bands 
containing enzymatic SeO3
2-
 reductase activity. Lanes in the gel correspond to step fractions taken from a 
HIC column to process crude cell lysate. Lanes correspond to 0.1 M, 0.5 M, 1.0 M, 1.5 M and 2.0 M 
elutions of the HIC column with (NH4)2SO4.  
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Figure 3.6 shows that two bands develop in the anaerobic SeO3
2-
 + NADPH incubation condition, 
one that is associated with lower salt elutions from the HIC column and a second associated with higher 
salt elutions.  
To identify the proteins involved in the observed reduction, we excised the bands and identified 
associated proteins by protein mass spectrometry.  From a total of 5 activity bands excised and analyzed 
for protein content, 122 proteins were identified.  Of these proteins ,7 are known to be NADPH or NADP
+
 
dependent.  This set of NADPH-dependent proteins (Table 3.1) comprises a set of candidate proteins for 
specific NADPH-dependent SeO3
2-
 reduction to Se(0). 
Table 3.1. NADPH-dependent enzymes identified in mass spectrometry. 
 
Of these proteins, we were especially interested in glutathione reductase (GSHR) and nitrite 
reductase, as each was previously implicated in selenite reduction.
38,57-59
 To validate the specificity and 
investigate the enzymatic mechanism, we obtained baker’s yeast (Saccharomyces cerevisiae) GSHR from 
Sigma-Aldrich (G3664) and the NADPH-dependent cytochrome C reductase (C3381) and Aspergillus 
niger nitrate reductase (N7265)  as comparison control enzymes.  Each enzyme was tested for 








 to zerovalent forms of Se and Te, respectively, 
as judged by a color change of the solution from clear to turbid red (Se) or gray (Te) upon inclusion of 
either NADH or NADPH as electron donors.  In this initial screening of enzymes and substrate 





no other combination resulted in notable metalloid oxyanion reduction. 
In order to understand the mechanism by which GSHR converts these metalloid oxyanions, we 




 substrates.  Km and Vmax were 
determined by observing the rate of consumption of NADPH, which has an easily observable 
34 
 
spectroscopic signature (Figure 3.7).  We found a KM of 31 mM for SeO3
2-
 and a KM of 0.54 mM for 
TeO3
2-
 (Figure 3.8).  The reported Km value of GSHR for GS-SG is ~50µM
60
 suggesting that the enzyme 
has a substantially higher substrate affinity for GS-SG than for SeO3
2-
. 
Figure 3.7. Example spectroscopic data showing enzymatic consumption of NADPH as judged by 
diminishment over time of the peak at 340 nm that arises from NADPH. Monitoring of this consumption 
(or lack thereof) allowed claims of substrate specificity and the Lineweaver-Burk plots show in Figure 
3.8. 




 reduction by GSHR. 
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were examined by TEM.   Reduction of TeO3
2-
 to Te(0) by GSHR produced networks of sub 5 nm 
particles, where the diameters are difficult to discern, similar to the previously reported enzymatic 
reduction of Ti
3+
 (as TiBALD) by cysteine and serine proteases.
34
 Reduction of SeO3
2-
 to Se(0) in 
otherwise identical conditions resulted in larger, discrete 61 ± 37 nm diameter SeNPs. Figure 3.9 shows 
electron micrographs of each product and a histogram of size distribution for the SeNP. 
Figure 3.9. Transmission electron micrographs of the characterization of in vitro products of GSHR 
reduction of TeO3
2-
 (panel A) and SeO3
2-
 (panel B). Panel C shows the size distribution histogram 
observed for GSHR produced SeNPs. 
 In the enzymatic assays, we observed that the steady-state phase of product production was 
remarkably short-lived (Figure 3.8).  We subsequently observed that the enzyme itself was consumed in 
the in vitro reaction, as determined by a Bradford assay for total protein (Figure 3.10, circles).  This 
suggested that the enzyme is associated with the particles it synthesizes, perhaps even entombed in the 
particle.  To test this hypothesis of association or entombment, we separated by centrifugation the 
enzymatically formed SeNPs from soluble enzyme.  The insoluble protein fraction corresponded to 18% 
of the total enzyme in the assay.  SeNPs are known to be dissolvable in solvents such as ethylenediamine 
and benzene.
61
 We found that enzymatically produced SeNPs are also soluble in Bradford protein assay.  
36 
 
In fact, we could recover nearly quantitatively the protein that disappears from the enzymatic assay in a 
Bradford assay of the enzymatically produced SeNPs.  This data is shown in Figure 3.10, left panel.  
There is evidence that the soluble fraction of GSHR is also associated with smaller SeNPs. In an SDS-
PAGE of the soluble fraction of GSHR, a difference in electrophoretic mobility coupled to a ‘smearing of 
the band’, consistent with the enzyme being bound to polydisperse particles, is observed in comparison to 
a control reaction. Overall, we suggest that some fraction of the enzyme is associated with or entombed in 
the nanoparticles that the enzyme creates.  When NADPH cofactor is omitted from the reaction, the 
enzymatic process does not proceed, and the observed enzyme concentration remains constant (Figure 
3.11, diamonds). 
Figure 3.10. Left panel shows the amount of GSHR lost from the assay at different NADPH cofactor 
concentrations in circles. In squares is depicted the amount of protein measured from the insoluble 
selenium particles created during the assay. The agreement between protein lost from the assay and 
protein recovered from the particles suggests that the enzyme is associated or entombed in the particles it 
creates. The right pane shows an SDS-PAGE of the soluble fraction of GSHR after an assay. The small 
shift in electrophoretic mobility and large smear about the band can be attributed to association between 
the enzyme and smaller SeNPs. 
The size of the enzymatically synthesized SeNPs is controllable through modulation of enzyme 
substrate concentrations. By varying the [NADPH] in an in vivo reaction, we observed that we could vary 
the size of the resulting particles from 2.5nm to more than 50nm diameter.  The effect of [NADPH] on 
particle size is shown in Figure 3.12. 
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Figure 3.11. The results of a Bradford assay of a fixed amount of GSHR exposed to varying amounts of 
NADPH, with SeO3
2-
 either present at 10 mM concentration (red squares) or absent (blue diamonds). 
When SeO32- is present (red squares) the enzyme vanishes from the assay in an NADPH dependent 
manner. 
Figure 3.12. Top panel shows how particle size changes as [NADPH] cofactor is varied. Bottom panel 
shows distribution of particle sizes (y-axis) as a function of [SeO3
2-




We identify the first polypeptide capable of soluble precursor reduction, retention of reduced 
product at the site of reduction, and size control of the reduced product.  This represents a notable step in 
progress toward a clonable nanoparticle, which is fundamentally different from other proposed strategies 
for clonable nanoparticles. First, other strategies rely on stoichiometric binding of metal ions,
4,5 
 or on 
oxidation events,
2 
 while this approach uses enzymes and NADPH as an electron donor to reduce 
inorganic precursors. We infer that the products of reduction are often retained by the enzyme that creates 
them, possibly by an entombing mechanism.  This rare combination of three activities in biogenic 
nanoparticle production was previously suggested for reduction of Au(III) precursors by the same 
enzyme.
35 
  In that work, however, the resulting particles are quite small, and as noted above, Au 
reduction is quite promiscuous by biomolecule
8 
 while the selenite and tellurite reductions reported here 
appear specific to just a handful of enzymes, as evidenced by Figure 3.6. 
We observe notable differences in the resulting size of particles, depending on the growth 
condition.  We cultured P. moraviensis Stanleyae cells for up to 36 hours in the presence of SeO3
2-
 
supplementation, to ensure an abundance of SeNPs in subsequent microscopic examination.  We grew 
cells for this extended time both with and without replacement of media. When the media was not 
replaced, it is likely that it is depleted of necessary nutrients at the 36 hour time point, and the cells are 
starving.  The starvation condition of cells in Figures 3.2 and 3.3 may partially explain the difference in 
average particle size observed between the intracellular particles in Figure 3.2 (107 nm diameter) and 
Figure 3.5 (58 nm diameter).  Notably, in Figure 3.4 the membranes are quite distorted, consistent with 
starving cells that are having difficulty maintaining homeostasis.  The starvation condition was avoided 
for cells reconstructed for Figure 3.5 by replacing the growth media every 12 hours.  Note that particle 
diameters measured for SeNPs in ‘healthy’ cells (58 nm diameter average diameter) and SeNPs produced 
in vitro by GSHR (61 nm average diameter) are within measurement error. This concurrence in particle 
size suggests that the in vitro and in vivo mechanisms that underlie the formation of these SeNPs are 
similar. Key for future application is minimizing the mass of the biological components of clonable 
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nanoparticles. For instance, the mass of GFP is 27 kDa, yet some studies have demonstrated that GFP 
concatemers can interrupt the native function of the protein fused to GFP.
61,62 
 A finding we make relevant 
to minimizing the mass of clonable nanoparticle tags is that the SeNPs described here may be effectively 
naked.   This stands in contrast to the well-established intracellular inorganic nanoparticles, which are 
coated either by a membrane or by a structured protein capsule. 
We hypothesize that the particles are naked, with the Se(0) exposed to the cytosol, from a 
combination of structural and chemical evidence.  From the tomographic reconstructions, we observe no 
evidence for a membrane around the SeNPs, while membranes are easily observed for naturally occurring 
magnetite nanoparticles.
55 
The low symmetry of the particles, dispersity, and differences in average size 
that depend on growth conditions suggest that there is no structured protein coat, such as that found with 
ferritin and DPS-coated nanoparticles. 
Chemically, we note that nearly all clusters and nanoparticles require a ligand shell to quench the 
chemical reactivity associated with the open valence electron shells of most pure elements.  A handful of 
elements, however, including Se and Te as well as As, Bi, and Sb are known to form stable naked cluster 
compounds.
63 
This is in many cases because the element can achieve noble gas-like electron counts by 
catenation, often resulting in ring structures in the solid state, such as the well-known Sn, Sen, and Ten ring 
compounds where 6<n<8.  Indeed, a recent report suggests that while the surface of SeNPs is more 
complex than an approximately scaled giant naked Se cluster, the surfaces are stable without formal 
ligation.
64
 Furthermore, protein mass spectrometry on purified SeNPs fails to identify candidate proteins 
that are known to interact with inorganic ions or surfaces.
37
 Thus, the combination of irregular symmetry, 
absence of a membrane, and plausibility of a ligand-free surface suggests that SeNPs may represent the 
first described class of cytosol exposed inorganic nanoparticle surfaces. 
The commercially sourced GSHR and GSHR or GSHR-like enzymes identified in P. moraviensis 
Stanleyae are not immediately useful as a clonable label in cellular EM.  First, the resulting SeNPs are 
substantially larger than practical; second, other GSHRs, nitrite reductases, and thioredoxin
65
 may also 
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produce background particles. While these enzymes are not characterized in vitro as producing SeNPs, 
they are characterized as using SeO3
2-
 as a substrate. We have not yet evaluated the portability of this 
clonable nanoparticle for use in other cell lines. The concentrations of SeO3
2-
 we used in both the in vitro 
and in vivo work herein are in the range where toxicity is expected for most cells and organisms.  The KM 
of the baker’s yeast enzyme is low, especially compared to oxidized GS-SG and GS-Se-SG substrates 
investigated historically for this enzyme.
60,66
 Due to the measured KM, the baker’s yeast GSHR will 
always require typically toxic concentrations of SeO3
2-
 for nanoparticle formation.  Furthermore, 
specialized selenium transporters that may be present in the selenium hyperaccumulator studied here may 
also enable the large intracellular particles observed in Figures 3.2 and 3.5. Thus, we anticipate cloning 
the GSHR-like enzyme from P. moraviensis Stanleyae, under the hypothesis that this selenium-
specialized enzyme will have a much more favorable KM, and that the enzyme may function well with 
physiologically normal concentrations of SeO3
2-
 while simulatenously conferring resistance to Se toxicity 
to cells in which it is expressed.  An enzyme optimized for selenite or tellurite reduction may allow 
superior labeling specificity by kinetically outrunning any competing reactions. 
While additional work is required to complete the adaptation of this clonable nanoparticle 
approach for general cellular use, this approach may find more immediate use in labeling purified 
macromolecular complexes.  Presently labeling with ex situ synthesized gold nanoparticles is state-of-the-
art for this purpose, with applications in molecular EM, X-ray free-electron laser, and SAXS studies of 
macromolecular complexes.
67
 A clonable approach to this contrast problem may make this sort of tagging 
much more facile. 
For instance, Se (and Te) oxyanions have notable advantages as precursors over previously 
investigated Au and Fe-based systems.  The Au(I) and Au(III) coordination compounds are broadly cross-
reactive (i.e.,  easily reduced into background particulate material) by a wide swath of biomolecules and 
buffers.
8,10,11
 This broad cross-reactivity may explain the dearth of follow up to reports of metallothionein 
/ Au combinations as molecular and cellular EM labels.    In contrast, the present work and some 
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 is comparatively limited in number.  
Improved size control may be imposed by concatenated or co-expressed peptides. Several 
dodecapeptides are now known to impose size control
28
 on a number of in vitro synthesized metal 
nanoparticles.
68
 Similar peptides may be isolated to impose size control on SeNPs or TeNPs. 
3.5 Conclusions 
In conclusion, we identify the first polypeptide that appears capable of synthesizing, retaining and 
size-controlling an inorganic nanoparticle.  By virtue of their metalloid composition, the particles may be 
naked and exposed to free cytosol.  We also find that metalloid oxyanions are comparatively selective in 
their cross-reactivity against biological molecules.  Overall, we suggest that metalloid reductases, 
including the GSHR-like reductase characterized here, comprise a class of enzymes that may find use in 
imaging applications needing a clonable nanoparticle.  
Further we also present a small 15 amino acid peptide that may also potentially be useful as a tag. 
While the size of the nanoparticle formed is in the ideal range of 3-5 nm, it may be difficult to utilize iron 
inside of a cell as iron ions are carefully corralled inside of a cell
77
 due to concerns of forming free 
radicals.
78,79
 While this peptide may be ineffective as a potential tag due to difficulties in controlling both 
iron concentration and iron species formation inside of a cell, it does still however display interesting 
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The Metalloid Reductase of Pseudomonas Moravenis stanleyae Conveys Nanoparticle Mediated 
Metalloid Tolerance 
4.1 Synopsis 
 A glutathione reductase-like enzyme in Pseudomonas moraviensis stanleyae was previously 
implicated as underlying the bacterium’s remarkable SeO3
2- 
tolerance. Herein, this enzyme is sequenced, 
recombinantly expressed and fully characterized.  The enzyme is highly adapted for selenodiglutathione 
substrates (KM = 336 μM ) compared to oxidized glutathione (KM= 8.22 μM).   Recombinant expression 
of this enzyme in laboratory strains of E. coli conveys a 10-fold increase IC90 for SeO3
2-
 .  Moreover, 
selenium nanoparticles are observed when the enzyme is overexpressed in cells exposed to SeO3
2-
, but not 
in corresponding no-enzyme controls.   Analysis of structural homology models of the enzyme reveal 
changes in parts of the enzyme associated with product release, which may underlie the Se-substrate 
specialization.  Combined, the observations of adaptation to Se reduction over oxidized glutathione 
reduction as well as the portability of this nanoparticle-mediated SeO3
2-
 tolerance into other cell lines 
suggests that the P. moraviensis glutathione reductase may be better described as a glutathione reductase-
like metalloid reductase. 
4.2 Introduction 
 Enzymatic conversion of soluble inorganic ions into insoluble forms is accomplished by enzyme 
centers such as those found in ferritin, magnetosomes and silicateins.  This enzymatic alteration in 
solubility state facilitates the synthesis of biogenic inorganic materials.
1–3
 These naturally occurring 
catalysts, in concert with accessory proteins, can exhibit control over subsequent materials composition, 
oxidation state, morphology and structure.  These natural precedents suggest that the intentional 
engineering of biological diversity could underlie engineered diversity in biogenically synthesized 
inorganic materials.  Such inorganic materials – made by laboratory evolved or engineered biomolecules 
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  Any self-contained biological system for synthesizing an inorganic nanostructure will generally 
require an oxidoreductase activity, enabling conversion of inorganic ions from soluble to insoluble 
oxidation states. Ferritins and DPS proteins accomplish this with ferroxidase enzymatic centers.
9,10
 
Silicateins accomplish this with substrate reduction through an active site serine,
11
 whereas we reported 




 We recently reported on the ability of glutathione reductase (GSHR) to enzymatically reduce 
selenite (SeO3
2-
) to zerovalent red selenium in a nicotinamide adenine dinucleotide phosphate (NADPH) 
dependent reaction.
13
 Similar, although diminished activity, was observed for the same enzyme in 
reducing tellurite (TeO3
2-
) to elemental Te.  Our prior work identified selenite reductase activity in 
Pseudomonas moravenis stanleyae.  This microbe attracted our attention because it is found as an 
endophyte in the selenium tolerant plant, Stanleya pinnata. When cultured independently in liquid media, 
it tolerates SeO3
2-
 supplementation in liquid culture up to 10mM.  This is 10-fold more than the SeO3
2-
 
tolerance of most other microbes. We attributed the observed selenite reduction activity of P. moravenis 
to a GSHR-like enzyme on the basis of proteomic mass spectrometry of an in-gel in situ selenium 
reductase activity.   
 GSHRs generally belong to the family of pyridine nucleoside dependent oxidoreductases. This 
enzyme family also, notably, includes another well-characterized metal reducing enzyme -- mercuric 
reductase.
14
 Within this enzyme family, active sites are highly conserved. Typical active site peptide 
sequences are CXXXXC for type I and CXXC for type II enzymes.
15
 This class of enzymes have 
demonstrated their ability to reduce a variety of metal ions to zerovalent forms including Se, Hg, Te, Fe, 
Cr, and U. 
16–19
 GSHR is reported to reduce Au(III) to zerovalent form as well.
20
 Thus, the class of 
pyridine nucleoside dependent oxidoreductases may represent an evolutionarily adaptable platform of 
49 
 
inorganic ion reductases, with modifications to the enzyme altering metal ion selectivity. Such a catalytic 
center, with alterable precursor selectivity, is of interest in biogenic inorganic nanoparticle synthesis.  
In prior study, we characterized commercially sourced Saccharomyces Cervisiae (S. Cervisiae) 
GSHR for selenite reductase activity, showing the ability of the enzyme to oxidize NADPH while 
reducing SeO3
2-
 to Se(0) nanoparticles.
13
 In the present study, we characterize a homologous metalloid 
reductase from the seleno-specialist P. moravenis. We find that the substrate selectivity of the metalloid 
reductase (KM) shows a substantially larger preference for GS-Se-SG relative to all other reported 
glutathione reductase enzymes. These enzymatic properties can be partially rationalized in terms of 
sequence and corresponding homology-modeled structure of the enzyme.  We also observe that 
expressing this enzyme in laboratory strains of E. Coli (BL21, SS320) results in increased tolerance to 
SeO3
2-
, as well as the presence of Se nanoparticles in these cells. Overall, our data suggests that the 
enzyme may be best described as a glutathione reductase-like-metalloid reductase (GRLMR). 
4.3 Results and Discussion 
 Altered substrate specificity of GRLMR enzymes, favoring selenodiglutathione (GS-Se-SG) over 
oxidized glutathione (GSSG) as a substrate could underlie the remarkable SeO3
2-
 tolerance of P. 
Moravenis stanleyae. We therefore characterized the P. Moravenis stanleyae GRLMR enzyme identified 
previously. The DNA sequence of the enzyme was acquired through a full-genome sequencing (ACGT 
Inc,Wheeling, IL). Sequencing was conducted using  de novo paired end sequencing.
21
 This revealed a 
genome where 70.3% of the nucleobases have, at the most, a 1:1000 probability of mis-assignment. 
Figure 5.3.1 shows the “Quality Score” (Q score) for each sequenced base with Q=-log10(e). Q scores, 
are derived from a phred-like error probability assessment of each individual nucleotide.
22
  
A BLAST search of the genomic sequence, using the Pseudomonas R-28S GSHR as a reference, 
identified one GSHR-like sequence, with 93% sequence homology.  Sequence alignment of this GRLMR 
DNA using Serial Cloner show high similarity (98.00%) to Pseudomonas fluorescines (P. fluorescines) 
GSHR and modest similarity (67 – 71%) to E. coli, S. cervisiae, and Homo sapiens (H. sapiens) GSHR 
DNA. The sequence similarities are summarized in Table 4.1, and full alignments are shown in Chapter 
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5.3.  The DNA sequence, combined with homology modeling of the structure suggest that all of the 
structural domains of Type I pyridine nucleotide dependent oxidoreductases, including catalytic, 
dimerization, nucleotide binding, and substrate/product binding domains
15,23,24
 are present in this enzyme. 
This GRLMR shows 19% DNA sequence homology to mercuric reductase from Pseudomonas 
Aeruginosa. 
Table 4.1. Sequence and structural homology. 
 PM MTLR PF GSHR EC GSHR SC GSHR HS GSHR 
PM MTLR  93.10%/ 1.56 74.14%/ 1.23 60.78%*/ 1.27 64.71%/ 1.31 
PF GSHR 98.00%/ 1.71  77.59%/ 1.05 75.47%*/ 1.12 68.00%*/ 1.07 
EC GSHR 67.42%/ 1.44 68.31%/ 1.42  81.48%*/ .87 79.63%*/ .85 
SC GHSR 70.92%/ 1.56 73.48%/ 1.33 74.61%/ 1.17  84.91%/ .56 
HS GSHR 70.34%/ 1.44 70.63%/ 1.24 78.97%/ 1.07 75.77%/ .92  
Sequence similarity (left value) and RMSD calculations (right values). PF- P. fluoresceine, EC- E. Coli, 
SC- S. cervisiaI, HS- H. sapiens. 
 
  Homology modeling using intensive parameters on the Phyre 2 server
25
 suggests that the structure 
of the Pseudomonas derived GSHR and GRLMR enzymes are homologous to other GSHR enzymes, 
despite modest DNA sequence divergence. Table 4.1 shows the root mean squared deviation of atomic 
positions (RMSD) values for a set of GSHR homology models and/or crysatal structures.  Overall, the 
RMSD values for these structures are similar, suggesting  an overall structural homology between 
GRLMR, and GSHR from P. fluorescines, E. Coli, H. sapiens, and S. Cervisiae. 
Under the hypothesis that the GRLMR enzyme has altered selectivity relative to other 
characterized GSHRs, we characterized the enzyme kinetics of both GRLMR and S. Cervisiae  GSHR.  
We expressed GRLMR recombinantly in E. Coli BL21 cells.  Following a 6x-histidine tag purification, 
we determined the Michaelis-Menton constants (KM) for both GRLMR and commercially sourced S. 
Cervisiae GSHR (Sigma, G3664).  The KM of each enzyme was determined for each of 3 substrates:  
SeO3
2-
, GSSG, and GS-Se-SG. While SeO3
2-
 (Alfa Aesar, 12585) and GSSG (Sigma, G4376) are 






Figure 4.1. Substrate activity assays (a) GRLMR, (c ) BY GSHR, with corresponding Lineweaver-Burke 
plots. b) GRLMR. d) BY GSHR. 
The enzymatic rates for both enzymes with both GSSG and GS-Se-SG substrates are plotted in 
Figure 4.1, panels a and c. Data is plotted as NADPH cofactor consumption, observed experimentally as 
depletion of a spectroscopic peak characteristic of NADPH (but not NADP) at 340nm.  The decay rate as 
measured at 340nm was converted to a normalized reaction rate. Lineweaver-Burke plots (shown as 
insets) were generated for each enzyme to determine Vmax and KM for the corresponding substrates.  The 
determined KM values for each enzyme/substrate combination are shown in Table 4.2. 
Table 4.2. Enzyme Kinetics. 
Enzyme/Substrate GRLMR Km SC GSHR Km GRLMR Vmax SC GSHR 
Vmax 
GSSG 8.22mM 103µM 2.62 .107 
GS-Se-SG 336µM 133µM .187 .137 
Vmax reported in (µMol/min)/(µg of enzyme). 
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For the GRLMR enzyme, we observe a remarkable specialization of the enzyme for GS-Se-SG 
over GSSG. Specifically the KM of GRLMR is 25 times more favorable for GS-Se-SG as compared to 
GSSG. This difference in KM for the two substrates strongly implies that the enzyme is specialized for Se-
reduction over GSSG reduction. For S. Cervisiae GSHR, we determined similar KM values for GSSG and 
GS-Se-SG substrates, with the enzyme showing a slightly greater affinity for GSSG. The values we find 




 The KM of 
GSHR for SeO3
2-
 has not been previously reported, to our knowledge. The physiological relevance of the 
SeO3
2-
 KM is questionable, since Se salts such as SeO3
2-
 are converted to GS-Se-SG in vivo.
 28
 We 
established here the KM for SeO3
2-
 for both GRLMR and S. Cervisiae GSHR because we identified 
GRLMR on the basis of SeO3
2-
 reductase activity, but note that the value is sufficiently unfavorable 
compared to GSH based substrates that it is unlikely to be physiologically relevant. 
The Vmax for GS-SG and GS-Se-SG substrates track in tandem up to initial concentrations of 0.20 
mM.  Deviations begin near a concentration of .3mM, where the rate for GS-Se-SG has reached its 
maximum velocity while the rate for oxidized glutathione continues to increase until roughly .6mM 
substrate concentration. The maximum velocity observed for the GSSG is approximately fourteen times 
greater than the Vmax for GS-Se-SG, but this occurs at a larger substrate concentration for GSSG, 
accounting for the lower affinity. It is possible that the fall-off in rate that we observe at higher GS-Se-SG 
concentrations is artifactual, arising from interference in the optical assay by the selenium nanoparticles 
produced during the experiment.  
Overall, the KM values we find suggest a strong substrate preference for GS-Se-SG for the 
GRLMR enzyme.  This is in contrast to essentially no differentiation between the substrates for other 
characterized GSHR enzymes. To our knowledge, this is the first finding of an enzyme specialized for 
reduction of GS-Se-SG over any other substrate..  
 We hypothesized that if the GRLMR conveys SeO3
2- 
tolerance to P. moravenis, then recombinant 
expression of this enzyme may convey similar tolerance to the host-organism for GRLMR expression.  
To evaluate this hypothesis, we transformed lab expression strains of E. coli, BL21 and SS320, with the 
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Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible expression vector described above.  For 
GRLMR enzyme-expressing E. coli, we determined selenite tolerance as the concentration of SeO3 that 
kills 90% of the cells (IC90). We also examined cells microscopically for presence or absence of SeNPs. 
For IC90 determination, identical volumes of cells were plated on LB-Agar and LB-Agar 
+ SeO3
2-
, each in triplicate, and grown overnight at 37C. The following day, colony forming 
units (cfus) were counted. IC90 was calculated as the percentage of cfus present relative to an 
identical control supplemented with 1µM SeO3
2-
.  We determined 1 µM SeO3
2-
 necessary for 
maximizing the number of observed cfus. We hypothesize that such supplementation is 
necessary because the overexpression of a SeO3
2-
 reducing enzyme in these cells reduces and 
makes unavailable the essential amount of Se needed as a micronutrient for optimum growth.
29
  
Figure 4.2. IC90 assays reported in percent inhibition vs. selenite concentration a) BL21 E. Coli cell lines 
with a GFP plasmid b) BL21cells with the GRLMR plasmid c.) SS320 cells with the GRLMR plasmid. 
Figure 4.2 shows relative growth inhibition as a function of selenite concentration. The 
log10[SeO3
2-
] gives a linear concentration dependence for SeO3
2-
 growth inhibition. This allows 
determination of the inhibitory concentration of selenite that eliminates 90% of cell growth (IC90).  We 
found an IC90 of 21.3±9.8mM  under conditions of GRLMR overexpression, whereas an IC90 of 
1.89±.46mM is observed in a corresponding control experiment. This result is at least somewhat cell-line 
independent.  When GRLMR is recombinantly overexpressed in E. Coli SS320, we observe an IC90 of 
18.3±19.5mM. Even with the large error bars a statistically significant increase in SeO3
2-
 tolerance is 
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induced by the presence of the GRLMR plasmid and we believe that the SS320 data is justified due to the 
similarly observed tolerance in the BL21 cell line. 
We note that the presence of recombinantly expressed enzyme results in the liquid cultures taking 
on the red color characteristic of the red allotrope of zerovalent selenium, whereas cultures grown with 
SeO3
2-
 without the recombinantly expressed enzyme do not take on this color.  To illustrate this, Figure 
4.3 shows cell cultures expressing the GRLMR (left panel) or GFP (right panel) in the presence of SeO3
2-
 
supplementation at 5 mM, after 3 hours of exposure.  This ‘bulk color’ change suggests that the cells 
expressing the recombinant enzyme may also be forming Se(0) nanoparticles just as we previously 
observed for the P. moravenis strain. 
Figure 4.3. Separation of selenium NP growth. BL21 cells with (right) and without (left) GRLMR 
plasmid after a 3 hour exposure to 5mM selenite supplemented LB. 
 
Examination of cells by SEM revealed the presence of selenium nanoparticles in cells expressing 
the recombinant enzyme and grown in Se supplemented media. Figure 4.4 shows scanning transmission 
electron micrographs of glutaraldehyde fixed dry-mounted BL21 E. coli cells expressing GFP or GRLMR 
after growth in SeO3
2-
 supplemented media. Both GFP and GRLMR cells show dark inclusions, with 
more inclusions observed in the GRLMR expressing cell line. Electron dispersive spectroscopy (EDS) 
mapping confirms that the dark inclusions are Se rich for the GRLMR cells, whereas any inclusions 
observed in GFP expressing cells show no evidence of Se presence. The corresponding EDS spectra 
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further confirms these conclusions by the presence of  signature selenium peaks being present for the 
GRLMR cells, and the absence of these peak for the GFP cells. 
Figure 4.4. SEM images (top) with EDS overlay (middle) of fixed cells after 3 hour exposure to 5mM 
selenite. a,c) Cells without GRLMR plasmid. b,d) Cells with GRLMR plasmid. Corresponding EDS 
spectra of cells without GRLMR (grey), and additional peaks from cells with GRLMR plasmid (red) on 
bottom. 
 
Previously, we observed that some fraction of nanoparticles synthesized by S. cervisiae 
GSHR were associated with the particle fraction.
13
  We examined the GRLMR for similar 
behavior.  Selenium particles were synthesized in vitro and were separated from the solution 
using centrifugation. The analysis of protein content in the solution and the particles were 
determined by Bradford assay (Bio-Rad).  Overall, approximately 10% of the enzyme is 
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associated with the selenium nanoparticles. This is a smaller fraction than we observed for S. 
cervisiae glutathione reductase (~18%), suggesting that the P. moravenis derived enzyme is 
more efficient at turning over or releasing the particles that they create.  Overall, this contributes 
to the picture of the GRLMR being specialized for conveying Se tolerance.  
Table 4.3. Key Glutathione Pocket Residues. 
 
Differences in the product/substrate binding pocket of this family of enzymes may underlie any 
observed differences in substrate specificity and enzyme activity. The key residues in the 
product/substrate binding area of GSHR are shown in Table 4.3, and models of this are shown in S.3.  
Structural alignment between GRLMR and P. fluorescines reveals an RMSD of 1.71 Å for the full 
enzyme and 1.56 Å for the product/substrate binding pocket. These values show the largest deviation 
between any of the enzymes considered here, but to the best of our knowledge no crystal structure of a 
Pseudomonas glutathione reductase has been obtained which would affect the generated structure models. 
The product/substrate binding pocket for GSHR contains a set of evolutionarily conserved 
residues, most notably including a cysteine that is implicated in glutathionylation regulatory mechanisms. 
There are three residues that dominate the binding interaction, one on an α-helix, and two on parallel β-
strands (βL, βR). Comparing our Pseudomonas enzymes we see that they contain the same key residues; 
α-Ser, βL-Lys, βR-Glu. (Figure 4.5.)
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Figure 4.5. Red- α residue, Teal- β residues, Yellow- GSH a) Yeast GHSR substrate binding pocket with 
bound GSH b) E. Coli GSHR substrate binding pocket c.) GRLMR substrate binding pocket. 
This absence of a sulfur-containing residue (Figure 4.1) in the P. moravenis  GRLMR, suggests 
that the enzyme is not subject to the glutathionylation regulatory mechanism well established for 
canonical glutathione reductase enzymes such as S. Cervisiae glutathione reductase. Glutathionylation of 
enzymes is a common post translation modification for proteins in signaling pathways and survival gene 
modification.
31–34
  This reversible post-translation modification is the binding of glutathione to an 
unpaired  cysteine residue.
35
 Such modification alters enzyme activity, presumably as a regulation 
mechanism.
36,37
 In the case of S. Cervisiae GSHR, glutathionylation at C239 (Figure 4.5) inhibits the 
enzyme. Chemically blocking the glutathionylation pathway is shown to increase GSHR activity by a 
factor of 2.1.
38
  Overall, the absence of the possibility of a glutathionylation regulation mechanism for the 
GRLMR enzyme suggests that it is distinct from other GSHR enzymes. 
The selenium metabolism literature highlights several examples of species within the 
Pseudomonas genus with remarkable tolerance to Se.  In many cases GSHR enzymes are implicated in 
the tolerance. GSHR was responsible for reducing selenite and tellurite to insoluble NP’s using the O-2 
strain of Pseudomonas maltophilia;
39 
 GSHR and thioredoxin reductase are responsible for selenite and 
selenate reduction in Pseudomonas seleniipraecipitansI. 
40–43
  The highly conserved sequence across 
species within the Pseudomonas genus, including conservation in the product/substrate binding pocket, is 
suggestive that the ability to handle normally toxic amounts of SeO3
2-
 may be a general feature of the 




In summary, we have characterized a glutathione reductase-like metalloid reductase (GRLMR) 
from the bacterium Pseudomonas moraviensis stanleyae.  Kinetic studies showed an overall decrease in 
substrate affinity for the GRLMR relative to the S. cervisiae GSHR, but an overall increased affinity for 
GS-Se-SG over GSSG. Transportability of the gene was tested by transforming lab strain E. Coli with 
GRLMR. Selenite tolerance increased ten-fold compared to cells without the gene, and the formation of 
elemental red selenium when GRLMR was present. SEM/EDS further confirmed this by showing 
selenium particles associated with cells containing the gene. Product association experiments showed a 
decrease in product retention when compared to S. cervisiae GSHR, which ultimately allows for increased 
product release and contributes to the overall Se tolerance. 
4.5 Materials and Methods 
Identification/Isolation 
An LB agar plate with colonies of the original P. moravenis cell line was submitted for full 
genome sequence. The DNA sequence from the most closely related enzyme identified by MALDI was 
used to identify the sequence of our enzyme of interest. This sequence was cloned into a pD441-CH E. 
Coli vector and a standard heatshock protocol was used to transform BL21 E. Coli. 
Standard protein purification was conducted by growing cells in 1L of LB to an optical density at 
600nm (O.D.600) of .6 and inducing protein expression with 1mM IPTG for 2 hours. Cells were collected 
and re-suspended in 25 ml of lysis buffer and lysed by tip sonication. The soluble cell lysate was collected 
and nickel-agarose beads were used to isolate and wash our expressed protein. 
GS-Se-SG Synthesis 
 Protocol from Ganther was followed for the synthesis of the selenodiglutathione.
26
 400umoles of 
HNaSeO3 was added to 24 ml of .1 M HCl and cooled to 4
o
C. Another solution of .1M GSH was cooled 
to 4
o
C and added quickly to the selenite solution. The mixture was allowed to react at 4
o
C for 20 minutes. 
2.5ml of 2M NaOAc was added to obtain a final pH of 4.5. A C18 column was used to separate the 
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products using pH 2.0 HCl. TLC was used to check the contents of lyophilized fractions. Isolated GS-Se-
SG was identified and the amount quantified using the UV-Vis absorption at 263 nm. (S.4) 
Km 
 1 ml reactions were conducted in 1x PBS with .1mM NADPH, and 15ug of either purified 
enzyme or S. cervisiae GSHR purchased from Sigma. Substrates tested were GSSG, GS-Se-SG, and 
selenite. Their concentrations were varied between reactions and the depletion of the NADPH peak at 340 
nm was monitored every 2 seconds after the contents were mixed. 
Transportability 
IC90’s were determined by standard plating experiments. In short a culture of BL21 cells 
containing either a plasmid with the GRLMR or a generic reporter gene were grown overnight in LB at 
37
o
C. The following morning 100 ul of this starter culture were added to 2.5ml of fresh LB and grown for 
roughly 2.5 hours to reach an O.D.600 of .6. Various amounts of selenite were added to each culture and 
exposure was continued for 24 hours. After exposure the cells were diluted 10
6
 fold and 20 uL of each 
dilution was plated in triplicate on 1x Kanamycin LB-Agar. Plates were put in the oven at 37
o
C and 
colonies were grown overnight and colonies were counted the following day. 
STEM 
3 mL of BL21 cells containing either a metalloid reductase gene or GFP reporter gene were 
grown separately in 10 mL culture tubes overnight containing LB medium (Teknova) supplemented with 
Kanamycin at 25ug/ml. The following morning the culture was added to a 125 mL Erlenmeyer flask 
containing LB medium supplemented with Kanamycin (25ug/ml). The cells were grown for 2.5 hours and 
100 mM Na2SeO3 (Alfa Aesar, 98+%) was added to reach a final concentration of 5mM. The cells were 
collected by centrifuging for 20 minutes at 4000 rpm and 4 
o
C after 3 hours of growth with selenite. Cells 
were washed with 20mM Tris (pH 7.4) (Fischer) three times followed by resuspension in 1 ml of fixing 
solution (2% gluteraldehyde (25% Sigma-Aldrich) and 2.5% formaldehyde); the fixing solution was 
alloed to react for 12 hours at 4 
o
C. The fixing solution was centrifugation and the pellet was washed five 
times in 20mM Tris (pH 7.4). The cells were resuspended in 1 ml 20 mM Tris (pH 7.4). Aliquots (4 uL) 
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were mounted on 400 mesh Cu grids with 50 nm C coating and washed two times with H2O. Dry-
mounted cells on TEM grids were loaded onto a STEM holder. STEM images were taken on a JEOL 
JSM-6500-F Scanning Electron Microscope at an accelerating voltage of 15 kV. 
EDS 
EDS was performed on P. moreviensis Stanleyae cells in the SEM as described above. EDS was 
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5.1 Chapter 2 Supporting Information 
Reagents 
The following chemicals were purchased from Sigma-Aldrich and used without further 
purification: Gold (III) chloride trihydrate (HAuCl4, ≥49.0% Au basis), L-glutathione reduced (GSH, 
≥98.0%), Boric Acid (H3BO3, ≥99.5%), Methanol (CH3OH, ≥99.8%), N,N,N,’N’-
Tetramethylethylenediamine (TEMED, ≥99%), N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide (EDC, 
98%), polyvinylpyrrolidone (PVP, 40MW), and Ammonium Persulfate (APS, ≥98%). The following 





-Cbz-L-lysine, >98.0%). Other reagents were purchased from Alfa Aesar, Thermo Scientific, 
and Sigma-Aldrich and used without further purification. Lithium sulfate (Li2SO4, ≥98.5%). 
Trimethylamine N-oxide (TMAO, ≥98%). Sodium Thiosulfate Anhydrous (Na2S2O3, ≥99%), Sodium 
Hydroxide (NaOH, ≥99%). Tris Hydochloride (C4H11NO3, ≥99%), Ethanol (EtOH, ≥88%), Ammonium 
Acetate (NH4OAc, ≥99%). L-Ascorbic Acid (C6H8O6, ≥99%) and Nitric Acid (HNO3, 70% Aqueous 
Solution) were purchased and used without further purification from Macron Chemicals. Ethylenediamine 
Tetraacetic Acid (EDTA, ≥99%) and Sodium Borohydride (NaBH4, ≥96%) were purchased and used 
without further purification from EMD Millipore. Acrylamide/Bis Solution (40%, 19:1) was purchased 
and used without further purification from Bio-Rad. 
Protein Crystal Preparation 
Full sequence information as well as expression and purification protocols for protein CJ 
(Genebank ID: cj0420, Protein Data Bank code: 2fgs) can be found in the published supplemental 
information here.
1 
CJ was crystallized overnight by sitting drop vapor diffusion in 3.2 to 3.6 M 
ammonium sulfate and 0.1 M BIS-TRIS at pH 6.5. Crystals were then transferred to a drop of 4.2 M 
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trimethylamine N-oxide (TMAO) and 50 mM imidazole to wash the crystal and equilibrate to the 
crosslinking solution. Crystals were crosslinked in 4.2 M TMAO, 50 mM imidazole, and 100 mM 1-
Ethyl-3-(3-dimethylaminopropyl) (EDC). After two hours in the crosslinking solution, incomplete 
crosslinks were quenched in 50 mM borate at pH 10 for 15 mins. After crosslinking and washing, crystals 
retained smooth, hexagonal morphology and clear color. 
Oxidoreductase protein (Protein Data Bank code: 3oc4) from Enterococcus faecalis was selected 
from a scan of the Protein Data Bank for proteins that crystallize with large pores. It was expressed in 





cells were lysed by sonication and purified via immobilized metal affinity chromatography. Purified 
protein was buffer exchanged into 150 mM NaCl, 10 mM HEPES, and 10% glycerol at pH 7.5 and 
characterized with SDS-Page. 
3oc4 was also crystallized overnight by vapor drop diffusion in 1.5 to 2 M sodium formate and 
0.1 M sodium acetate at pH 4.6. Crystals were washed and equilibrated in a drop of 4.2 M TMAO and 50 
mM imidazole for 10 mins. Next, crystals were crosslinked in 4.2 M TMAO, 50 mM imidazole, and 100 
mM EDC. After two hours in the crosslinking solution, the crystals were quenched in 50 mM borate at 
pH 10 for 15 mins. After crosslinking and washing, crystals retained smooth, elliptical morphology and 
clear to slightly yellow color. 
Gold synthesis 
Na3Au(S2O3)2 was synthesized using previously published methods.
3
 Approximately 2 ml of 15 
M NaOH was added dropwise to 3.65 ml of 0.1 M HAuCl4 dissolved in H2O until a white precipitate 
formed at approximately pH 8.5. After stirring for 5 mins, 10.16 mL of Na2S2O3 (5.18 g) dissolved in 
water was added at once and was allowed to continue stirring for 5 mins. Approximately 1.8 ml of 4 M 
HNO3 was added dropwise until a red color change was no longer seen after each drop addition. The 
reaction was filtered and washed x4 with 100 mL EtOH. The precipitate was dissolved in 20 mL H2O 
followed by EtOH precipitation using 80 mL of solvent. The precipitate was filtered and washed x3 with 
80 mL of EtOH. 
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Au25(GSH)18 was synthesized using previously published methods.
4
 98.6 mg HAuCl4 were 
dissolved in 50 mL of MeOH. 0.3062 g of reduced glutathione (GSH) were added to the solution and 
stirred until colorless. The contents were placed in an ice bath for 30 mins along with 12 mL of 0.2 M 
NaBH4. The NaBH4 was added rapidly to the solution under vigorous stirring. The reaction was allowed 
to stir for 1 hr. The contents were spun at 4000 rpm for 10 mins. The supernatant was discarded and 
pellets were dispersed in 2 mL of H2O followed by the addition of 200 uL of 5 M NH4OAc and 48 mL 
MeOH. After spinning at 4000 rpm for 10 mins the supernatant was again discarded. The previous steps 
were repeated x2 and the pellet was allowed to dry. The clusters were further separated using 24% Tris-
Borate-EDTA (TBE) buffered polyacrylamide gel electrophoresis (PAGE) run at 125 V for 4.5 hrs. 
Au25(NTA)(GSH)17 was synthesized using a common ligand exchange reaction. Briefly dried and purified 
Au25(GSH)18 was dissolved in H2O and five equivalents of HS-NTA was added. This reaction was 
allowed to shake for 7.5 minutes.
5
 The products were then precipitated using MeOH and 200 µL of 5 M 
NH4OAc. After collection using centrifugation the precipitate was dried under reduced pressure. 
Gold growth with chloroauric acid 
The following protocol was used to encourage maximum gold growth within the crystal pores. 
Gold nanorods can be obtained using this protocol with or without first adsorbing a gold nanoparticles 
(Au25(GSH)17NTA) into the pores as nucleation sites. Seeded or unseeded crystals were placed in 10 mM 
chloroauric acid (HAuCl4) for 10 to 30 mins or until the crystals turned a bright yellow color. We 
hypothesize there are electrostatic interactions that cause adsorption of Au
+3
 within the crystal. Next, 
crystals were moved to 10 mM ascorbic acid until black (Fig 5.1.1). Crystals typically turn black within 
10 mins, but may darken for up to 24 hrs. 
67 
 
Figure 5.1.1. (a) A CJ protein crystal after loading in 10 mM HAuCl4 for 10 mins. (b) A CJ protein 
crystal after transfer to 10 mM ascorbic acid for 1 hr. (c) CJ crystals grown by the same method but 
viewed with an overhead brightfield light to better display the complete presence of metallic gold. Scale 
bar is 100 um. 
 
We investigated the effects of loading time of gold seeds (Au25) and Au
+3 
ions on the amount of 
growth within the crystal. In summary, with no seed present, crystals may sometimes turn completely 
black by eye, but typically look more grey with particles crashed out in the surrounding well. When gold 
seeds were loaded into the crystal for only 5 mins before growth, the crystal took longer (up to overnight) 
to turn completely black. Whereas crystals that were loaded with Au25 for 1 hr prior to growth typically 
turned fully black within 20 mins of placement in 10 mM ascorbic acid. Additionally, the length of 
chloroauric loading had an effect on overall growth. When the length of loading time was increased to 16 
hrs, crystals did not turn completely black in any case during reduction (independent of seed loading 
time). Additionally more aggregation and nucleation within the drop was seen.  
We also investigated the effect of NiSO4 (used for locking the nitrilotriacetic acid ligand on the Au25 
particle to the Histidine tag on the crystal) on spontaneous nucleation. As we had noticed that with this 
method, Au25 was not needed to produce nucleation. Without NiSO4 present, spontaneous nucleation 
could be slowed, but not fully prevented, so NiSO4 was used in future experiments to preserve the specific 
attachment of the gold seed within the crystal pore. 
Additionally, we explored the effect of pH on overall gold growth. Most experiments were 
carried out at pH 7.0. When the pH was changed to 9.0, much less overall growth occurred. We 
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hypothesized that this is because some gold structures are more stable at higher pH. At pH 5.0, much 
more aggregation occurred within the well, but did not aid in overall growth within the crystal. 
In some early attempts at complete gold growth within the crystal we attempted to create a growth 
solution which contained both chloroauric acid and ascorbic acid. We hypothesized that when a seeded 
crystal was placed in this growth solution, rod formation and particle growth would preferentially occur 
within the crystal pores in the presence of a seed, locked in place by Ni(II). However, even upon changing 
solution concentrations, we found only that uncontrolled growth occurred within the well and often at the 
surface of the crystal, suggesting some favorable electrostatics between the crystal and the soluble gold 
(Fig. 5.1.2). 
Figure 5.1.2. An Au25 seeded CJ crystal after 1 hr of exposure to a mixture of 5 mM HAuCl4 and 5 mM 
ascorbic acid. Crystal is approximately 300 um in diameter at its widest point.  
We determined that multiple rounds of growth can be performed to encourage further darkening 
of the crystal and presumably more growth within the pores. Once a crystal had been through one round 
of growth (Au25, HAuCl4, ascorbic acid), it was placed back into a fresh drop of HAuCl4, then again into 
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ascorbic acid. This “stepwise” growth caused darker crystals by eye after multiple rounds (Fig. 5.1.3), but 
we found that the rods present were no longer than those that could be produced by one round of growth. 
We suspect that prolonged exposure to the growth solutions may cause some etching of the longest, most 
fragile rods (Fig. 5.1.4). 
Figure 5.1.3. A CJ crystal after (a) one, (b) two, and (c) three rounds of growth with HAuCl4 and ascorbic 
acid. Crystals are approximately 300 um in diameter at their longest point.  
 
Figure 5.1.4. Transmission electron microscopy of structures resulting when a CJ crystal is subjected to 
six “rounds” of growth and then dissolved. Scale bar is 150 nm. 
 
To confirm some of these anecdotal growth observations made by optical microscope (regarding 
the effect of Au25 and HAuCl4 loading times), we dissolved many crystals and viewed the resulting 
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structures under transmission electron microscopy. Figure 5.1.6 shows the differences in gold products 
with and without the presence of Au25 as a nucleation point and with and without ascorbic acid as a 
reducing agent. These results show that although gold nanoparticles (and sometimes rods) are formed in 
the absence of a gold seed, rods were more plentiful and longer when a seed is present. Additionally, a 
lack of reducing agent leads to almost no particle formation.  
Figure 5.1.5 depicts via optical microscopy the case in which no chloroauric acid is added to the crystal 
(Au25 seeds within the crystal are simply exposed to ascorbic acid). Here there is no color change by eye 
and only Au25 particles visible by TEM. 
Figure 5.1.5. A CJ crystal loaded with Au25 seeds and exposed to 10 mM ascorbic acid for 16 hrs results 
in no color change, thereby no apparent particle growth or rod formation. The crystal is approximately 




Figure 5.1.6. TEM of the resulting gold structures when a (a & b) seeded or (c & d) unseeded CJ crystals 
are grown in 10 mM HAuCl4 for 10 mins, transferred to a drop of 10 mM ascorbic acid for 1 hr, and then 
dissolved. (e & f) TEM of seeded CJ crystal loaded with 10 mM HAuCl4 for 10 mins and then dissolved 
shows that reduction is required for nanoparticle growth. Scale bars are (a & b) 200 nm, (c & d) 300 nm, 
and ( e & f) 100 nm. 
 
Additionally, we confirmed our visual observation that leaving a CJ crystal soaking in HAuCl4 
overnight before reduction may prevent rod formation. We believe this is because more self-nucleation 
occurred, including outside the crystal, which created only particles. Figure 5.1.7 shows typical TEM 
results from a normal versus extended HAuCl4 loading time. 
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Figure 5.1.7. Left: A gold structures within a CJ crystal loaded with Au25(GSH)17NTA for 30 mins, 
HAuCl4 for 10 mins, reduced by ascorbic acid, then dissolved for imaging. Right: The results when the 
HAuCl4 loading time is increased to 16 hrs. Scale bars are 200 nm. 
 
The overall quantity of seeds present in the crystals before nucleation affected the products 
observed. We demonstrated this effect by varying the Au25 loading time which can be seen in Figure 
5.1.8. The sample with a longer Au25 loading time appears to have only made smaller particles, while the 
sample with a shorter Au25 loading time formed larger particles and rods with low aspect ratios. We 
believe the results of these experiments are caused by altering the amount of nucleation sites for growth. 
The longer loading time of the seed will result in more available seed sights once nucleation is initiated in 
the growth step, ultimately leading to more particles. When a short seed load time is used there may be 
less available nucleation sites leading to large particles and more rod formation. 
Figure 5.1.8. Left: CJ crystals load with Au25 seeds for 30 mins before gold growth, scale bar is 200 nm. 





Apart from looking at seed loading time effects we also carried out an experiment in which we 
varied the loading time of HAuCl4 prior to reductant addition. 1, 3, and 4 minute, 10 mM HAuCl4 soaking 
times were carried out and the resulting products after crystal dissolving can be seen in Figure S9. No 
images were obtained for the 1 minute Au
3+
 soak sample due to the lack of any products on the TEM grid. 
The 3 min Au
3+
 soak sample showed the formation of particles with an average diameter of 8.8 nm with a 
standard deviation of 2.9 nm (n=75). Four minutes of Au
3+
 soak time showed the development of rods 
with an average width of 25.0 nm with a standard deviation of 8.5 nm (n=33) and an average length of 
79.8 nm with a standard deviation of 33.1 nm (n=34). In general, the longer Au
+3
 loading time resulted in 
the presence of more gold nanostructures. 
Figure 5.1.9: Top Row: Gold structures resulting from a 3 minute HAuCl4 loading time. Bottom Row: 
Gold structures resulting from a 4 minute HAuCl4 loading time. 
 
Although there was significant variation between trials, this method of growth produced the 
longest overall rods we saw (870 nm). There were numerous rods between 500 and 700 nm in length. 
Possible reasons for the variability in products include impurities in the well that may provide nucleation 
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sites and variability in the chloroauric acid samples. Figure S10 shows some examples of the types of 
structures we saw from this protocol. Panels a and b are high resolution transmission electron microscopy 
images of some of the longer rods grown in CJ crystals. Of note in panel b are the perpendicular segments 
that connect the four rods. CJ crystals have lateral pores that may account for this attachment (Fig. 
5.1.10). In panels c and d, there are many nanoparticles of varying sizes surrounding the rods. Panel e 
shows an only partially dissolved crystal still surrounding gold nanorods. Panel f shows some of the 
shorter rods produced by this growth method, and illustrates the bundles of rods that tend to form when 
the crystal is dissolved. 
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Figure 5.1.10. TEM of dissolved CJ crystals after seeded growth by HAuCl4 and ascorbic acid. (a & b) 
High resolution TEM. Scale bar (a) 100 nm (b) 50 nm. Scale bar (c & d) 100 nm. Scale bar (e & f) 200 
nm. 
 
To demonstrate the versatility of this growth method, we grew gold structures within crosslinked 
CJ protein crystals using two other “seed” particles as nucleation sites: Au102(pMBA)44 and 5 nm diameter 
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gold nanoparticles (5nm AuNP) with tannic acid surface ligands. In both cases, the seed particle was 
allow to adsorb into the crystal before transfer to 10 mM HAuCl4, then 10 mM ascorbic acid. Color 
change was seen in 1 hr, suggesting the presence of larger gold structures within the crystals. The 5nm 
AuNP seed also showed good control of growth between a seeded and unseeded crystal (Fig. 5.1.11 and 
5.1.12). 
Figure 5.1.11. (a) CJ crystal in a solution containing Au102(pMBA)44 (b) The same CJ crystal after 
adsorption of HAuCl4 and 16 hrs in ascorbic acid. Scale bar is 100 nm. 
Figure 5.1.12. (a) CJ crystal after 3 days in 1 mg/mL 5nm AuNP. (b) The crystal from (a) after transfer to 
HAuCl4 then ascorbic acid. (c) A similiarly prepared CJ crystal that was not loaded with 5nm AuNP 
before transfer to HAuCl4 and ascorbic acid. This crystal shows minimal preferential gold growth within 




We also grew mixed metal nanostructures within the CJ crystal pores by using Au25 as a 
nucleation site for silver growth, using a Silver Enhancer Kit from Sigma Aldrich (Product ID: SE100). 
Figure 5.1.13 shows the results of one such experiment. Panels a-c show an Au25 loaded CJ crystal in the 
silver growth solution over time, while panels d-f show a similar crystal in the growth solution over time, 
but without a pre-loaded Au25 seed. Over 24 hrs, the seeded crystal undergoes a more significant color 
change than the unseeded crystal. 
Figure 5.1.13. An Au25 loaded (top row) or not (bottom row) CJ crystal in the silver growth solution at t 
= 0 (a & d), t = 15 min (b & e), and t = 24 hrs (c & f). Scale bars are 100 nm. 
 
Gold growth with surface passivating agents 
The following protocol is adapted from
6
 and was used to encourage growth only when a 
nucleation point in the form of Au25(GSH)17NTA is present. In a glass vial under constant stirring, the 
following solutions were combined: 2 ml of water, 200 µl of 5% (w/v) polyvinylpyrrolidone (PVP), 200 
µl of 0.2 M potassium iodide (KI), 200 µl of 0.1 M ascorbic acid, and 30 µl of 0.25 M HAuCl4. The 
solution should be clear and remain clear for at least 2 hrs.  
Separately, a CJ crystal was loaded with 1 mg/mL Au25(GSH)17NTA in phosphate buffered saline 
(PBS) at pH 7.4 for 30 mins. This “seed” was bound by moving the crystal to a drop of 1 mM NiSO4 for 5 
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mins and then washing with water for 1 min. This crystal was then placed in a 40 uL drop of the growth 
solution prepared above. After 10 mins, the crystal was black. This protocol could be repeated on the 
same crystal every 10 mins to encourage further growth. An empty crystal, one that has not been loaded 
with gold nanoparticles, remained clear when placed in the growth solution. Figure 5.1.14 shows TEM of 
the structures resulting after the crystal scaffold was dissolved. The anisotropic shapes (hexagons, prisms, 
etc.) are representative of the shape that this growth method produces when unconfined, as PVP acts as a 
crystal-face-blocking ligand.
7
 Panel a shows that the heavily grown crystals may not have been 
completely dissolved by our methods. We visually checked these samples for complete growth through 
the interior of the crystal by cutting open CJ crystals (Fig. 5.1.15); we saw that the interior of the crystal 
was filled with gold. We hypothesize that we are synthesizing a substantial amount of gold throughout the 
crystals with this method, such that there are many interconnects among rods (which we have seen in 
TEM - Fig. 5.1.10b) that make it difficult to fully dissolve the crystal. We also hypothesize that the larger 
structures seen in Figure 5.1.14b and Figure 5.1.14c were grown from seeds on the surface of the crystal, 
and thus were not size restricted by the pores. 
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Figure 5.1.14. TEM images of the structures resulting after a crystal is subjected to the above growth 
protocol and then dissolved. (a) What we believe to be an incompletely dissolved crystal, where the 
interior gold structures are still connected by partially denatured protein. Scale bar is 300 nm. (b & c) 









Figure 5.1.15. A crystal grown by the above method and cut into pieces to reveal gold growth throughout 
the interior. 
 
Gold growth with thiolated precursors 
The following protocols were used to encourage stable growth of seeded crystals with minimal 
self-nucleation due to the decreased reduction potential of sodium aurothiosulfate compared to that of 
chloroauric acid. 
Pre-reduction gold growth: A CJ crystal was loaded with 1 mg/mL Au25(GSH)17NTA in 
phosphate buffered saline (PBS) at pH 7.4 for 30 mins. The gold seed was then bound using 1 mM NiSO4 
for 5 mins, followed by a water wash for 1 min. The crystal was then moved into a drop of 10 mM 
sodium cyanoborohydride (NaBH3CN) for 30 mins. No change in color or morphology was observed. 
The liquid was pipetted away and the crystal was washed with water for 1 min. The crystal was then 
moved to a 1 mM sodium aurothiosulfate (Au(I)) solution and observed for 15 mins. This procedure was 
repeated for a crystal that was not loaded with 1 mg/mL Au25(GSH)17NTA. There was no growth of the 
seeded crystal and no growth of the unseeded crystal.  
Alternately, a CJ crystal loaded with with 1 mg/mL Au25(GSH)17NTA in phosphate buffered saline (PBS) 
at pH 7.4 for 30 mins while another remained empty. The seeded and unseeded crystals were both bound 
using 1 mM NiSO4 for 5 mins. Both crystals underwent a water wash for 1 min. Each crystal was placed 
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into 100 mM sodium borohydride (NaBH4) for 30 mins. Then, the crystals were moved to 1 mM Au(I) 
and observed for 10 mins. No growth was observed for both the seeded and unseeded crystals.  
Post-reduction gold growth: A CJ crystal was loaded with 1 mg/mL Au25(GSH)17NTA in phosphate 
buffered saline (PBS) at pH 7.4 for 30 mins. A control crystal remained unseeded. Both crystals were 
moved to 1 mM NiSO4 for 5 mins then placed in a water wash for 1 min. The crystals moved to a 1 mM 
Au(I) for 1 hour, then moved to the reducing solution of 10 mM NaBH4 and observed for 10 mins. 
This protocol was repeated for differing ratios of concentrations of Au(I) to NaBH4. These variations 
include 10 mM Au(I) to 100 mM NaBH4 and 10 mM Au(I) to 10 mM NaBH4. As expected, the largest 
amount of growth occurred when there was a 10 mM Au(I) to 100 mM NaBH4 concentration ratio, 
however there was little separation of growth between the seeded and unseeded crystals. The best 
separation of growth occurred at 1 mM Au(I) to 10 mM NaBH4 ratio (Fig. 5.1.16) but the seeded growth 
was not as abundant as that of the higher concentration of Au(I) and NaBH4. In all cases, the seeded 
crystal turned a dark brown shade and the unseeded crystal ranged from a light to a dark gray color 
dependent upon solution concentrations. At high concentrations the unseeded crystal had no separation of 
growth from the seeded crystal. Separation of growth was seen using 1mM Au(I) and 10mM NaBH4 after 
the samples were left in the growth solution for approximately 2 months. The seeded crystal was 
completely black, while the unseeded crystal was clear. 
Figure 5.1.16. CJ crystals loaded (black) or not (grey) with Au25, then subjected to gold growth with 1 
mM Au(I) followed by 10 mM NaBH4. 
We dissolved some of the most successful attempts at seed-mediated Au(I) gold nanorod growth 
to view by transmission electron microscopy (Fig. 5.1.18). We found that the seeded crystal (panel a) 
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contained many large particles and other amorphous structures, while the unseeded crystal (panel b) was 
almost entirely empty.  
However, as with most growth methods outlined in this paper, there were inexplicable instances 
where unseeded crystals (which should not contain defined nucleation points for gold growth) 
spontaneously grew gold structures as evidenced by their color change. Figure 5.1.17 shows transmission 
electron microscopy of one such instance, where an unseeded crystal, loaded with 1 mM Au(I) and 
transferred to 10 mM NaBH4 turned dark in color by eye, and when dissolved showed evidence of some 
short rods and many particles by TEM. This highlights the precision required to prepare the crystals and 
solutions so that spontaneous nucleation is minimized. 
Figure 5.1.17. An unseeded CJ crystal grown in 1 mM Au(I) and 10 mM NaBH4 and dissolved for 
imaging by TEM. The image on the right shows evidence of gold nanorod formation within the partially 
dissolved protein matrix, while the image on the left shows some large particles and elliptical structures. 
We then attempted to form gold nanorods from Au(I) reduction by increasing the concentrations 
to 100 mM Au(I) and 100 mM NaBH4. These crystals showed no separation of growth visually, and when 
dissolved, some rods were evident (Fig. 5.1.19). 
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Figure 5.1.18. Transmission electron microscopy crystals from Figure 5.1.16. A CJ crystal that has been 
loaded with Au25 (a), subjected to gold growth by Au(I) and NaBH4, and then dissolved, contains mostly 
gold particles. A CJ crystal that was unseeded upon gold growth (b) remains devoid of larger gold 
particles. 
Figure 5.1.19. The short rods and rod bundles that result from gold growth within a seeded CJ crystal 









Gold growth in 3oc4 crystals 
In order to demonstrate the versatility of this method for synthesizing gold nanostructures in 
arbitrary shapes, we prepared an alterate protein crystal scaffold. The protein crystal (PDB code 3oc4), 
crystallizes with 9 nm and 5 nm cylindrical axial pores and 5 nm lateral pores (Fig. 5.1.20). 
Figure 5.1.20. Molecular Python (Pymol) of the top (left) and side (right) view of a 3oc4 crystal. 
We hypothesized that we could grow gold nanorods by the same method within the pores of 
3oc4, and when the crystal was dissolved, we would see gold nanostructures that matched the dimensions 
of the scaffold. Figure 5.1.21 shows the general topology of a 3oc4 crystal, as well as its color after 
loading 10 mM HAuCl4 for 1 hr (a) and 10 mM ascorbic acid for 1 hr (b). Figures 5.1.22 shows the 




Figure 5.1.21. (a) Crosslinked 3oc4 crystals previously loaded with Au25, now adsorbing 10 mM HAuCl4. 
(b) The 3oc4 crystals from (a) after 1 hr in 10 mM ascorbic acid. Scale bar is 100 nm. 
 
 
Figure 5.1.22. TEM of rods released from 3oc4 crystals that have been loaded with Au25 and soaked in 10 
mM HAuCl4 and 10 mM ascorbic acid. 
 
Dissolving crystals for TEM 
Protein crystals were dissolved using a variety of methods. Crystals were soaked in 
approximately 200 uL of 0.5 M NaOH either at room temp, at 35
o
C, or at 200 rpm and 40
o
C. For specific 
experiments detailed below, the dissolving solutions were supplemented with 0.1 M glutathione (GSH) as 
a capping agent. Dissolving was considered finished when no sign of the crystal was seen under an optical 
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microscope. This could take anywhere from 4 hrs to 7 days depending on the density of growth within the 
crystal and the overall size of the crystal. 
We often found that using much smaller crystals aided in our ability to quickly dissolve the samples and 
release the gold nanorods for imaging. Typical CJ protein crystals are between 100 um and up to 1 mm. 
However by altering the crystal growth conditions, crystals under 1 um in diameter can be grown, whose 
height is likely limited to 50 nm (Fig. 5.1.23). 
Figure 5.1.23. Transmission electron microscopy of several “microcrystals” whose pores are filled with 
gold nanostructures. 
These “microcrystals” are prepared by a batch method. Instead of individually transferring or 
looping each crystal into a new solution, a 1 mL sample of microcrystals can be moved to each new 
solution (i.e. crosslinking, quenching, Au25 loading, etc.) by centrifugation and supernatant removal. By 
this method, we were able to synthesize many microcrystals filled with gold in one process. Additionally, 
these microcrystals dissolve much more quickly than their larger counterparts. Microcrystals were 
dissolved using a standardized method. 10 uL of microcrystals suspended in H2O were added to 500 uL of 
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dissolving solution (0.5 M NaOH, 0.1 M GSH) and put in an oven at 35
o
C for 4 hours. The products were 
centrifuged at 14,000 rpm for 30 minutes and the supernatant was discarded. Products were then re-
suspended in water. 
It became apparent that a universal dissolving protocol was unattainable for larger crystals, and 
variations in the dissolving method were needed for different samples created. The following section is 
intended to summarize the dissolving variations and their implications. 
Extended dissolving times needed to dissolve heavily grown crystals tend to convert rods to 
particles and particles to small particles. A pair of +/- Au25 crystals grown with 1 mM Au(I) and 10 mM 
NaBH4 were dissolved at 40
o
C and 250 rpm in 0.5 M NaOH and 0.1 M GSH. The -Au25 sample dissolved 
within 3 days, while the +Au25 sample took 1 month to dissolve. Both crystals appeared to have a similar 
amount of growth as seen by eye before dissolving, but once plated onto TEM grids, particles and some 
rods were seen in the unseeded sample (Fig. 5.1.24) and the grid was blank for the +Au25 sample. This 
suggests that extended dissolving periods allow for product etching, and conversion of nanorods to 
nanoparticles which is supported by previous studies.
8-10
 The magnitude of the effect demonstrated here is 
twofold due to previous observations, which showed a correlation between darker grown crystals, or more 
heavily grown crystals, and their need for longer dissolving times. 
Alterations in the dissolving protocols varied in their affect on observed products. A pair of 
samples seen in Figure 5.1.24 show the rod clumps observed after one sample was exposed to slightly 
higher heat and stirring for 24 more hours (b). This example shows that stirring has no noticeable effect 







Figure 5.1.24. (a) Nanorod clump derived from a crystal exposed to 0.5 M NaOH at 35
o
C for 2 days. (b) 
Nanorod clump derived from a crystal exposed to 0.5 M NaOH at 40
o
C and 250 rpm for 3 days. Scale 
bars are 200 nm. 
 
In Figure 5.1.25, we can see that sonication of the dissolved rods using a water bath (3 min) has 
no noticeable effect on the rods observed. The rods in panel a have an average diameter of 21.4 nm (±3.8, 
n=630) while the rods in panel b have an average rod width of 22.8 nm (±4.3, n=603). 
Figure 5.1.25. (a) Gold nanorods after dissolving in NaOH and KCl at pH 13. (b) Gold nanorods after 
dissolving in the same buffer with the addition of 3 min bath sonication. Scale bars are 100 nm. 
 
The addition of GSH did have an effect on the rods observed, but was based on the amount of 
growth that occurred in the crystal, which appeared to vary from trial to trial. Figure 5.1.26(a) shows a rod 
clump resulting from crystals being dissolved at 35
o
C for 3 days in 0.5 M NaOH. Figure 5.1.26(c) was 
dissolved under the same parameters with supplementation of 0.1 M GSH. It is clear that GSH helps 
break rod clumps and exposes portions of the protein crystal that would be difficult to dissolve. It should 
be noted that exposure to GSH for this length of time results in rod etching, leading to an average 
diameter of 13.5nm (±2.6, n=185). Glutathione’s ability to disrupt rod clumps is oxygen dependent, 
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which is shown in Figure 5.1.26(d) (dissolved in air free conditions). As shown in Figure 5.1.26(b), we 
found that by exposure to GSH, we could reduce the effect of etching. 
Figure 5.1.26. (a) Rods acquired from a crystal dissolved in 0.5 M NaOH at 35
o
C for 3 days. (b) Rods 
acquired from microcrystals dissolve in 0.5 M NaOH and 0.1 M GSH at 35
o
C for 4 hrs. (c) Rods acquired 
from a crystal dissolved in 0.5 M NaOH and 0.1 M GSH at 35
o
C for 3 days. (d) Rods acquired from a 
crystal dissolved in 0.5 M NaOH and 0.1 M GSH at 35
o
C for 3 days under Argon. Scale bars are 200 nm. 
With all of these variables taken into consideration we were unable to find a reliable universal 
dissolving method for all samples. Extended exposure to thiols and heat will inevitably etch rods and lead 
to increased nanoparticle yields, but limited exposure time does not appreciably effect obtained products. 
It should be noted that the addition of thiols and heat to the original high pH dissolving solution were only 
used for heavily grown samples that would not dissolve in a reasonable amount of time otherwise. 
In addition, we attempted some more creative dissolving methods to help break apart remaining protein 
structures that often disrupted our imaging ability. We used a solution of cyanogen bromide, which is 
reported to cleave the protein backbone adjacent to the C-terminus of methionine residues, to attempt to 
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fully dissolve the protein crystal. However, the chemical crosslinks prevented the crystal from losing it’s 
structure (Fig. 5.1.27). 
Figure 5.1.27. A gold grown CJ protein crystal in a drop of 0.1 M cyanogen bromide (CNBr). Although 
CNBr cleaves peptides, the chemical crosslinking by EDC held the protein in place and did not allow for 
separation of the gold nanostructures. Crystal is approximately 400 nm across. 
We used a combination of 4.2 M guanidine hydrochloride (GdnHCl) and 15% hydroxylamine to 
denature the protein and cleave ester bonds in EDC crosslinks, respectively. This was successful, but we 
found that hydroxylamine was significantly etching rods and making it difficult to interpret our products 








Figure 5.1.28. A gold grown CJ protein crystal in a 10 uL drop of 4.2 M GdnHCl and 15% 
hydroxylamine at (a) t = 0, (b) t = 4 hrs, and (c) t = 16 hrs. By 16 hrs, the crystal has dissolved and gold 
nanostructures remain visible in the drop of liquid. (d) TEM images of the gold structures resulting from 
the above sample. Although this solution completely dissolved the protein crystal, it also appeared to etch 
the gold products. Some hint of rods remain, but are difficult to interpret. Original crystals (a) were 
approximately 200 um in size, and expanded to ~300 um in GdnHCl (b).  Scale bar for (d) is 200 nm. 
Electron microscopy 
To obtain TEM images of released gold nanorods, solutions of the grown and dissolved protein 
crystals were spun at 14,000 rpm for 30 minutes and the supernatant was decanted. The remaining 
solution (approximately 10 uL) was used to suspend the rods and 4uL of this solution was mounted onto 
200 mesh Cu grids with a 50 nm carbon coating (Ted Pella Inc.). TEM images were taken on a JEOL-
1400 Transmission Electron Microscope at an accelerating voltage of 100 kV. A tilt series from ±60
o
 was 
collected on a rod bundle in 0.5
o
 increments suing the JEOL-1400 TEM mentioned above. IMOD was 
used to generate a 3D reconstruction from the acquired tilt series. 
For high resolution TEM/STEM (scanning transmission electron microscopy), gold nanorods 
were mounted as explained above, and images were taken on a JEOL JEM2100F Transmission Electron 
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Microscope at 200 kV. STEM images were collected using a Gatan 806 HAADF detector and Nano 
Beam Diffraction was used to collect electron diffraction of rods in 10 nm increments (Fig. 5.1.29). 
Figure 5.1.29. Left Panel: Electron diffraction heat map taken every 10 nm on a gold rod bundle with 6 
highlighted segments. Right Panels (1-6): Electron diffraction patterns corresponding to the highlight 
regions in the left panel. 
 
In-situ imaging of gold rods grown within crystal pores 
We used a variety of methods to attempt to view the gold nanostructures within intact crystal 
pores. Our first attempts involved ultramicrotomy of resin embedded crystal samples for observation by 
transmission electron microscopy (TEM). Gold grown crystals were embedded following previously 
published methods.
11
 Briefly, a hard grade Epon resin mixture containing 50% resin monomer, 35% nadic 
methyl anhydride, and 15% dodecenyl succinic anhydride was lowly introduced to the crystal solution, 
beginning with 5% resin mixture in acetone (v/v). Over three days this was increased to 100% with 
shaking. Accelerator (dimethylaminemethyl phenol) was added to the resin at the 100% step. The resin 
mixture, with crystal embedded, was cured over two days at 60
o
C. The samples were cut to ~ 90 nm thick 
on a Riechert Ultracut E using a glass or diamond knife and imaged by TEM as described above.  
It was apparent when cutting the thin sections that the difference in mechanical properties 
between the gold and the protein/resin was causing the sample to warp or shear when cutting, a common 
problem when imaging composite materials. When these samples were viewed under TEM, we saw 
1 2 3 
4 5 6 
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evidence of sheering and buckling (an example can be seen in Figure 5.1.30). Physical deformation of this 
kind would easily destroy any crystallographic periodicity before imaging could occur. 
Figure 5.1.30: Thin section of resin embedded crystal shows shearing and buckling under TEM. 
Next, we attempted scanning electron microscopy (SEM) on gold grown crystals that were cut 
into pieces to expose the interior of the crystal. Figure S31 shows that while cutting/smashing the crystals 
clearly caused damage to the protein, the bright spots of high electron density suggest the presence of 





Figure 5.1.31. Scanning electron microscopy of gold grown CJ crystals cut into pieces to expose the 
interior of the crystal. 
Given the possibility for distortion during cutting, we next fractured grown crystals under liquid 
N2 to help preserve their structure. Specifically, liquid N2 was poured into a well containing gold grown 
crystals. A frozen crystal manipulation tool was used to crush the crystal sample. The frozen pieces were 
then transferred to a TEM grid. Figure 5.1.32 shows the results of this imaging method. Panel a suggests 
the presence of a ~20 nm electron dense rod that is half exposed and half crystal embedded after the 
shattering procedure. Panel b again suggests the presence of ~20 nm electron dense rods still completely 
embedded in the crystal after shattering. Panel c shows evidence for potential axial pore growth with 




Figure 5.1.32. TEM images of gold grown CJ protein crystals frozen under liquid N2 and shattered to 
reveal the interior of the crystals. (a) Gold nanorod, partially crystal embedded and partially exposed. (b) 
Two nanorods trapped within the crystal. (c) Evidence for axial pore growth within the crystal. (d) 
Zoomed in section of the approximately 4 nm rods embedded in the crystal from image C. Scale bar is 20 
nm. 
Additionally we attempted to confirm the presence of gold through energy-dispersive X-ray 
spectroscopy (EDS) of thick sections of grown crystals. We again resin embedded gold grown CJ crystals 
(by the same method described for ultramicrotoming), but instead used a glass knife to cut thick sections 
(2-3 um) of the sample. These were placed on a grid for SEM/EDS imaging. By EDS, we were able to 
detect significant presence of gold within the interior of the crystal. However, the crystal and resin 
surrounding the embedded sample was very beam sensitive and prevented viewing and focusing on the 
sample for extended periods of time due to beam damage. 
Because we are able to grow microcrystals that are less than 1 um in diameter and theoretically less than 
200 nm in thickness, we attempted to visualize intact, gold grown crystals by TEM (see Fig. 5.1.23 
above). Unfortunately at room temperature the samples were too sensitive for the amount of beam power 
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that would be required to image at the needed resolution. Additionally, we believe that the distance 
between axial pores in the CJ crystal (<3 nm) approaches the resolution limit to detect separation between 
gold rods in adjacent pores. 
Elemental analysis 
The elemental analysis samples consisted of three replicates, each containing three crystals 
loaded with gold nanoparticles and dissolved in 2 mL of aqua regia. Volumes were calculated by 
measuring the surface areas and heights of the crystals using a calibrated optical microscope. Samples 
were prepared by loading crosslinked CJ crystals with Au25(GSH)17NTA overnight, binding the seed with 
Ni(II), moving the crystal to a drop of 10 mM HAuCl4 for 1 hr, and lastly reducing the gold in a drop of 
10 mM ascorbic acid until black. Elemental Analysis was performed at Midwest Laboratories, Inc. 
Further information regarding in crystallo gold loading concentrations and theoretical gold packing 
calculations can be found here.
1 
Rod diameter and length analysis 
After TEM image acquisition, rod widths and lengths were analyzed using ImageJ software. Rod 
lengths varied significantly between 10 and 900 nm. A histogram of occurrences for a total of 453 








Figure 5.1.33. Histogram of frequencies of occurrence of rod length and width (a) unseeded length (b) 
Unseeded width (c) Seeded length (d) Seeded width (e) Seeded and sonicated products length and (f) 
width. 
Due to the variation in rod width within a single rod, multiple measurements were made per rod. 
CJ crystal axial pores are ~13.1 nm in diameter, but the average rod width over all growth methods and 




 Figure 5.1.34. Histogram of frequencies of occurrence of rod widths and lengths from (a & b) GdnHCl 
and HA and heat (c & d) GSH and heat and (e & f) 6x growth cycles. A total of 2496 measurements were 
taken over 452 rods and four different crystal dissolving conditions. 
 
For multiple samples, we measured crystal surface areas before and after gold growth and 





Figure 5.1.35. (a) CJ crystal loaded with Au25. (b) CJ crystal from (a) after 10 mins in HAuCl4 then 10 
mM ascorbic acid at t = 1 hr. The white dotted line roughly indicates the original outer area of the crystal. 
The calculations shown in the diagram below help explain how this phenomenon of pore and 
crystal swelling may take place. Before gold growth (top left) the 13 nm diameter pore is within a 
translated unit cells of 18 nm side length. The total area is 281 nm
2
, with the pore consisting of 133 nm
2
 
and the protein approximately 148 nm
2
. With the new pore diameter of 20 nm, equal to that of the gold 
rods grown within, and assuming retention of the same unit cell angles, the new minimum total unit cell 
area is 462 nm
2
 and the new protein area remains the same at 148 nm
2
. In fact, a 20 nm diameter circle is 
the largest circle that can be contained within a parallelogram whose non-circle area (grey areas in 
diagrams below) are limited to 148 nm
2
. In other words, 20 nm is as large in diameter as the gold 
nanorods can become without breaking or expanding the unit cell in some way. For example (bottom 
right), a gold nanorod of hypothetical 21 nm diameter would require a total protein (grey) area of 158 nm
2
 
to be fully contained, which is larger than the protein area available per unit cell of the CJ crystal.      
Without significant denaturation, the overall volume of the protein within the crystal should not change. 
We hypothesize here that the force of the fast and significant gold growth was able to move the protein 
‘out of the way’ up until the point of actually breaking peptide bonds, denaturing the protein, or severing 
crosslinks between monomers. Looking more closely, the growth of the gold nanorods expands one 
corner of the unit cell (length a) by 1 nm while contracting the adjacent corner (length b) by 1 nm. The 
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corners of these diagrams correspond to a tetramer (interface of four CJ monomers) within the crystal, 
which is also the location of some of the most flexible loops and helices in the crystal structure, most 
likely allowing for more than enough room to make these changes in area. 
Figure 5.1.36. Area calculations due to pore swelling after gold nanorod growth. 
To further explore how the gold growth can distort the protein crystal pores, we used 1% 
gluteraldehyde as an alternate crosslinker to EDC. Gluteraldehyde is a more aggressive crosslinker that is 
capable of polymerizing and forming covalent linkages between more sites, and we hypothesized that 
rods grown within the pores of gluteraldehyde-crosslinked CJ crystals might have smaller diameters than 
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those grown in EDC crosslinked crystals. Most rods were superimposed on others within bundles, so only 
a few individual rods were able to be accurately measured. The average width of rods growth in this type 
of crosslinked crystal were 15.2 nm with a standard deviation of 1.7 nm (n=19) (Fig. 5.1.37). These 
results may suggest that rods grown in more rigid crystals will have an overall smaller width due less 
crystal expansion. 
Figure 5.1.37. Gold nanorods resulting from a gluteraldehyde-crosslinked CJ crystal grown with 10 mM 
HAuCl4 and 10 mM ascorbic acid and dissolved for TEM. 
Pore space visualization
12 
To visualize the major solvent channels in CJ crystals we started with the recent CJ structure (pdb 
code: 5W17) with improved resolution (2.58Å). 
We then used the map_channels_v0.5 software (CITATION BELOW) to generate a “cast” of the 
solvent channels (“./map_channels 5w17.pdb –cm”). The resulting pdb file consisted of a field of dummy 
atoms on a hexagonal grid with an automatically selected grid spacing of 2.24 Å. We pruned this cast by 
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excluding all grid points that were less than 4 Å from a protein atom. Within PyMOL we then used the 
supercell.py utility (contributed to the PyMOL wiki by Thomas Holder) to generate a 2 x 2 x 3 collection 
of unit cells. To observe the fine structure in the minor solvent channels most clearly, we excluded the top 
40% of the uppermost unit cells. We then completed the visualization for Figure 1b in chapter 2 in 
PyMOL using a smooth Gaussian surface representation (gaussian_resolution = 7) for the solvent 
channels (b=50, q=1, 3 Å grid, 6 Å buffer, 0.1 isosurface level). 
PyMOL commands for gaussian surface representation: 
set surface_quality, 1 
alter all, b=50 
alter all, q=1 
set gaussian_resolution, 7 
map_new mapB, gaussian, 3, all, 6 
isosurface surfB, mapB, 0.1 
5.2 Chapter 3 Supporting Information 
Cell Lysate Preparation 
P. moraviensis Stanleyae cells were grown for 24 h at 30 °C in 2,800-mL Fernbach flasks 
containing 1 L of LB-Miller medium supplemented with 10 mM Na2SeO3. Cells were harvested via 
centrifugation at 10,000 x g for 20 minutes and the pellet resuspended in 15 ml of ice-cold 25 mM Tris 
and 192 mM glycine buffer (pH 8.3) supplemented with 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride 
hydrochloride (AEBSF) and 0.02% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate 
hydrate (CHAPS). Then, cells were treated with 0.2 mg mL-1 lysozyme (Sigma-Aldrich, St. Louis) for 20 
min in a 100 rpm shaking incubator at 30°C. Following lysozyme treatment, the cells were homogenized 
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via a French pressure cell operated at 120 MPa. The procedure was repeated twice and this final 
homogenate was spun at 22,500 x g for 60 min at 4°C to remove unbroken cells and cell debris. These 




P. moraviensis Stanleyae cells were grown for 24 h at 30 °C in a 125 mL Erlenmeyer flask 
containing 50 mL LB medium (Teknova) supplemented with 10 mM HNaSeO3 (Alfa Aesar, 98+%). Cells 
were harvested via centrifugation at 4,000 rpm (3,220 rcf) for 20 minutes at 4 °C. Cells were then washed 
in 20 mM Tris (pH 7.4) (Fisher) three times followed by resuspension in 1 mL of fixing fixative solution 
(2% glutaraldehyde (25%, Sigma-Aldrich) and 2.5% formaldehyde); the fixing solution was allowed to 
react for 6 h at 4 °C. Post-fixation, the fixing solution was removed by centrifugation and the pellet was 
washed five times in 20 mM Tris (pH 7.4). The cells were then resuspended in 1 mL 20 mM Tris (pH 
7.4). Aliquots (2 μL) were mounted on 400 mesh Cu grids with a 50 nm C coating. Dry-mounted cells on 
TEM grids were loaded onto a STEM holder. STEM images were taken on a JEOL JSM-6500-F 
Scanning Electron Microscope at an accelerating voltage of 30 kV. 
EDS 
EDS was performed on P. moreviensis Stanleyae cells in the SEM as described above. EDS was 
collected on a Noran System 7 X-ray Microanalysis detector with a time interval of 1 s. 
Dry-mount cellular TEM 
P. moraviensis Stanleyae cells were grown for 24 h at 30 °C in a 125 mL Erlenmeyer flask 
containing 50 mL LB medium (Teknova) supplemented with 10 mM HNaSeO3 (Alfa Aesar, 98+%). Cells 
were harvested via centrifugation at 4,000 rpm (3,220 rcf) for 20 minutes at 4 °C. Cells were then washed 
in 20 mM Tris (pH 7.4) (Fisher) three times followed by resuspension in 1 mL of fixing fixative solution 
(2% glutaraldehyde (25%, Sigma-Aldrich) and 2.5% formaldehyde); the fixing solution was allowed to 
react for 6 h at 4 °C. Post-fixation, the fixing solution was removed by centrifugation and the pellet was 
washed five times in 20 mM Tris (pH 7.4). The cells were then resuspended in 1 mL 20 mM Tris (pH 
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7.4). Aliquots (2 μL) were mounted on 400 mesh Cu grids with a 50 nm C coating. TEM images were 
taken on a JEOL JEM-1400 Transmission Electron Microscope at an accelerating voltage of 100 kV. 
3D EM 
Cells Harvested at 6, 6, 12 hours post selenium inoculation 
A single colony was picked from an LB agar plate of P. moraviensis Stanleyae and placed into 3 
ml of LB culture media and incubated aerated at 160 RPM, overnight at 28 
o
C. The cells were harvested 
and rinsed 2 times with sterile phosphate-buffered saline (PBS) and then resuspended into 200 mL of 
fresh LB media. Half of the flasks were given a 10 mM final concentration of HNaSeO3, the other half an 
equivalent amount of media as control. The cultures were shaken at 160 RPM at 28 
o
C and samples were 
collected 6, 9, and 12 hours post Se inoculation. They were high pressure frozen using a Wohlwend 
Compact 02 (Technotrade) high pressure freezer into aluminum planchettes. Samples were freeze-
substituted in 0.2% osmium tetroxide, 0.1% uranyl acetate, and 5% water in acetone using the fast-freeze 
substitution method
15
 over 3 hours. Samples were rinsed in acetone and embedded in epon (EMS) over 
several days. 200 nm sections were cut using a Ultracut UCT (Leica) microtome with a diamond knife 
(Diatome) and placed on formvar-coated copper slot grids. Sections were post-stained with 2% aqueous 
uranyl acetate and lead citrate. 15 nm gold fiducials were added. 
Dual-axis tilt-series were acquired using SerialEM
16
 on a Tecnai TF20 (FEI) transmission 
electron microscope from +/-60, 1 degree intervals on an Ultrascan digital camera (Gatan) at a pixel size 
of 0.91 nm. Tomograms were reconstructed using IMOD.
17
 A total of 23 tomograms were collected 
which are detailed below. 
+6 hours control: 3 TS 
+6 hours Se: 3 TS 
+9 hours control: 3 TS 
+9 hours Se: 3 TS 
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+12 hours control: 3 TS 
+12 hours Se: 3 TS  
36 hours control, dried: 1 TS  
36 hours Se, dried: 1 TS  
36 hours Se, resin: 1 TS 
Cell Harvested at 36 Hours Post Se Inoculation 
Cells were grown as previously described in the dry-mount cellular TEM methods. Differences in 
the procedure were that the cells were grown for 36 hours and the media was changed every 12 hours. 
Media was exchanged by centrifuging cells at 4,000 rpm at 4 °C for five minutes. The supernatant was 
poured out and new LB was added and the cells were then resuspended and allowed to continue growing. 
Cells were fixed at 36 hours as described in the dry-mount cellular TEM methods. Chemically fixed cells 
were rinsed 2 times in dH20 and then went through a graduated dehydration series into 100% acetone. 
They were infiltrated with epon (EMS) over several days. 300 nm sections were cut using an Ultracut 
UCT (Leica) microtome with a diamond knife (Diatome) and placed on formvar-coated copper slot grids. 
Samples did not undergo post-stain. 10 nm fiducials were added. Single-axis tilt-series were acquired 
using SerialEM
4
 on a Tecnai TF30 (FEI) transmission electron microscope from +/-60, 1 degree intervals 





Reconstructions were sectioned using IMOD.
17
 The outer cell walls were segmented every 5 
tomographic slices on the XY plane. An isosurface was generated and the threshold lowered to determine 
a cutoff value for imodauto to differentiate cellular background from SeNP. Imodauto was set at a 
threshold of 1 (out of 255), which generated a model with both the gold fiducials and the SeNPs. The 
models were merged and the outline of the cell was meshed to generate the image. 
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Native Polyacrylamide Gels 
Native polyacrylamide gels were used to check for selenite reduction capabilities utilizing the 
procedure described by Hunter.
18
 Briefly, cell lysate was purified via HIC column then separated on a 8% 
non-denaturing polyacrylamide electrophoresis gel (Invitrogen, Carlsbad, CA) using a Novex® Tris-
Glycine Native Running Buffer (Invitrogen). Following electrophoresis, gels were placed into zip-lock 
bags filled with Ar and assayed for selenite reduction capability. Assay was performed by incubation of 
the gel in a solution of 50 mM HEPES (pH 7.5), 200 mM Na2SeO3 and 1mM NADPH. Bands that turned 
red were excised for further study. 
Protein MS/MS 
SDS-PAGE and In-Gel Trypsin Digestion for LC-MS/MS 
Bands of interest were excised from the gel and processed for in-gel trypsin digestion and 
LCMS/MS as previously described.
19
 Briefly, the gel pieces were washed with 200 μL of LC-MS Grade 
Water (Optima LC-MS, Fisher Scientific) for 30s and destained with 2 x 200 μL of 50% Acetonitrile 
(ACN; Optima LC-MS Grade)/50 mM ammonium bicarbonate at 60 
o
C, with intermittent mixing. The 
pieces were dehydrated with 100% ACN and dried via vacuum centrifugation in a SpeedVac for 5 min. 
Proteins were reduced and alkylated, in-gel with 25 mM DTT in 50 mM ammonium bicarbonate (60°C 
for 20 min) and 55 mM IAA in 50 mM ammonium bicarbonate at room temperature in the dark for 20 
min. Gel pieces were then washed with Optima water and dried. The dried gel pieces were rehydrated in 
20 μL 12 ng/μL MS-grade Trypsin (ThermoPierce, San Jose, CA) /0.01% ProteaseMAX surfactant/50 
mM ammonium bicarbonate mixture for 10 min at room temperature, overlaid with 30 μL 0.01% 
ProteaseMAX surfactant/50 mM ammonium bicarbonate and incubated at 50 °C for 1 h. Extracted 
peptides were transferred and the digestion halted by addition of 10% trifluoro-acetic acid to a final 
concentration of 0.5%. Peptide extracts were dehydrated and stored at −20 °C prior to analysis by LC-
MS/MS. 
Peptides were purified and concentrated using an on-line enrichment column (Thermo Scientific 
5 mm, 100 mm ID x 2 cm C18 column). Subsequent chromatographic separation was performed on a 
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reverse phase nanospray column (Thermo Scientific EASYnano-LC, 3 mm, 75 mm ID x 100 mm C18 
column) using a 30 minute linear gradient from 10%-30% buffer B (100% ACN, 0.1% formic acid) at a 
flow rate of 400 nanoliters/min. Peptides were eluted directly into the mass spectrometer (Thermo 
Scientific Orbitrap Velos). The instrument was operated in Orbitrap-LTQ mode where precursor 
measurements were acquired in the Orbitrap (60,000 resolution) and MS/MS spectra (top 20) were 
acquired in the LTQ ion trap with a normalized collision energy of 35kV. Mass spectra were collected 
over a m/z range of 400-2000 Da using a dynamic exclusion limit of 2 MS/MS spectra of a given peptide 
mass for 30 s (exclusion duration of 90 s). Compound lists of the resulting spectra were generated using 
Xcalibur 2.2 software (Thermo Scientific) with a S/N threshold of 1.5 and 1 scan/group. 
GHSR TEM 
Glutathione reductase Se nanoparticles were made by mixing 25 μL(66 μg) of glutathione 
reductase (from S. cerevisiae) with 500 μL 100 mM selenite (HNaSeO3), 100 μL 10mM NADPH and 275 
μL 10x PBS (pH 7.4). The solution was allowed to mix for an hour, at which point the solution turned 
red. The samples were centrifuged and the pellet washed with 1x PBS (pH 7.4). Particles were then 
mounted onto 400 mesh Cu grids with a 50 nm C coating (Electron Microscopy Sciences). TEM images 
were taken on a JEOL JEM-1400 Transmission Electron Microscope at an accelerating voltage of 100 
kV. 
SeO3/TeO3 Assays 
Samples (1 ml) were made using a constant NADPH concentration (0.36 mM) in PBS. Varying 
selenite/tellurite concentrations were used (1 mM to 1 M). All blanks contained the same content as the 
reactions except NADPH. 5 L (13 μg) of glutathione reductase was added to the reaction and A340 
measurements were obtained every 2 seconds for the first 10 minutes, every 10 seconds for the next 20 
minutes, followed by every minute for the next 30 minutes. The decrease in absorbance at 340 nm was 




Protein Concentration Assay 
Four 315 uL samples were created in 1x PBS, 10mM selenite, and equal amounts of Baker’s 
yeast glutathione reductase from Sigma Aldrich. The samples had varying NADPH concentrations from 0 
to 6mM and were allowed to react for approximately 20 hours. Once the reaction was completed the 
samples were centrifuged at 14000 rpm for 30 minutes to remove any synthesized nanoparticles. The 
supernatants were collected and a Bradford assay was performed in triplicate on the four samples in a 1:9 
ratio of sample to reagent. The nanoparticle pellets were then washed with water two times to remove any 
free protein, followed by redispersion of the pellets in .005% SDS. These samples were then run through 
the assay in the same ratio also in triplicate. Two standard curves were made, one using GSHR in 1x PBS 
and one using GSHR in .005% SDS. 
SDS Gel Assay 
Seven 315 uL samples were created in 1x PBS, six in 4mM NADPH and a control with no 
NADPH. The six samples contained a range of selenite from 0 to 10mM while the control contained no 
selenite. An equal amount of Baker’s yeast glutathione reductase from Sigma Aldrich was added to each 
sample and allowed to react for approximately 20 hours. The samples were spun down at 14000 rpm for 
30 minutes to remove any synthesized nanoparticles. Following this, a 4-15% SDS gel from Bio-rad was 
set up with each well containing 25 uL of a solution made from 25uL sample in 5 uL of SDS loading dye 
(Bio-Rad). The gel was run at 110 V for 75 minutes. After staining with Coomassie Brilliant Blue G-250 
followed by de-staining, the gel was imaged with a Bio-Rad GelDoc XR. It should also be noted that 
another set of samples were created which contained 1/3 of the protein as the SDS samples. Three 
samples were created under the exact same conditions as stated before apart from the difference in added 
enzyme. The samples consisted of a control of GSHR in 1x PBS, and two samples containing 4mM 
NADPH. One of the cofactor samples contained no selenite and the other with a final concentration of 
10mM. A 6% native gel was casted and six wells were loaded with 25uL of a solution made from 25uL 
sample and 5 uL SDS loading dye. The first three wells were filled with samples containing the lowered 
amount of added enzyme, while the last three wells contained samples with the added enzyme mentioned 
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in the beginning of this section. This gel was run at 110 V for 1 hour and was stained with Coomassie 





Figure 5.2.1. Raw EDS data taken indicating locations of detected energies of elements. The K edge of 
chlorine, selenium, and carbon dominates the EDS spectrum. We interpret these images as follows: 
Carbon localizes throughout the image, due to the carbon support film on which the cells are mounted. 
Chlorine localizes within the cell boundaries, accounting for physiological saline within the cell. 











5.3 Chapter 4 Supporting Information 
Figure 5.3.1. Phred-like quality scores (Q scores) used to measure the accuracy of the genome 
sequencing data. Higher Q scores indicate a smaller probability that a base is incorrectly assigned. 
DNA Sequence Alignment 
Alignment of Pseudo Metalloid Reductase Protein Sequence with Pseudomonas Flourescene GSHR 
Protein Sequence 
Similarity : 442/451 (98.00 %) 
 
PM MTLR      -AYDFDLYVIGAGSGGVRAARFAAGFGAKVAVAESRYLGGTCVNVGCVPKKLLVYGAHFA  59 
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
PF GSHR      MAYDFDLYVIGAGSGGVRAARFAAGFGAKVAVAESRYLGGTCVNVGCVPKKLLVYGAHFA  60 
 
PM MTLR      EDFEQASGFGWNLGEANFDWATLIANKDREINRLNGIYRNLLVNSGVTLHEAHAKIVGPH  119 
             ||||| ||||||||||:||||||||||||||||||||||||||||||||||||||||||| 
PF GSHR      EDFEQSSGFGWNLGEADFDWATLIANKDREINRLNGIYRNLLVNSGVTLHEAHAKIVGPH  120 
 
PM MTLR      EVEVNGERFTAKNILIATGGWPQIPGIPGHEHAIGSNEAFFLKELPKRVLVVGGGYIAVE  179 
             |||||||| |||||||||||||||| ||||||||:||:|||||||||||||||||||||| 
PF GSHR      EVEVNGERYTAKNILIATGGWPQIPEIPGHEHAISSNQAFFLKELPKRVLVVGGGYIAVE  180 
 
PM MTLR      FAGIFHGLGANTTLLYRGDLFLRGFDGSVRKHLQEELTKRGLDLQFNADIARIDKQADGS  239 
             ||||||||||||||||||||||||||||||:||:|||||||:|||||||||||||| ||| 
PF GSHR      FAGIFHGLGANTTLLYRGDLFLRGFDGSVRNHLKEELTKRGMDLQFNADIARIDKQSDGS  240 
 
PM MTLR      LKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFIKVDGEYQTTEPSILAL  299 
             ||||||||||||||||||||||||||||||||||||||||||||||| :||||||||||| 
PF GSHR      LKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFIKVDEQYQTTEPSILAL  300 
 
PM MTLR      GDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFSLPNIGTVGLSEEEARE  359 
             ||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||| 
PF GSHR      GDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFSLPNIGTVGLTEEEARE  360 
 
PM MTLR      CGHEVVIFESRFRPMKLTLTDCQEKTLMKLVVDARTDKVLGCHMVGPDAGEIVQGLAIAL  419 
              ||:|||:||||||||||||||||:|||||||| : |||||||||||||||||||||||| 
PF GSHR      AGHDVVIYESRFRPMKLTLTDCQERTLMKLVVDGKSDKVLGCHMVGPDAGEIVQGLAIAL  420 
 
PM MTLR      KAGATKRDFDDTIGVHPTAAEEFVTMRTPVSA  451 
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             ||||||||||||||||||||||||||||||:| 
PF GSHR      KAGATKRDFDDTIGVHPTAAEEFVTMRTPVGA  452 
 
Alignment of Pseudo Metalloid Reductase Protein Sequence with E. Coli GSHR Protein Sequence 
Similarity : 300/445 (67.42 %) 
 
PM MTLR      AYDFDLY-VI-GAGSGGVRAARFAAGFGAKVAVAESRY-LG-GTCVNVGCVPKKLLVYGA  56 
              :: | | :| | ::|:::::| |:  :  :::: :::    :::::|: :  :  :::: 
EC GSHR      TKHYD-YIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPKKVMWHAAQIR  59 
 
PM MTLR      HFAEDFEQASGFGWNLGEANFDWATLIANKDREINRLNGIYRNLLVNSGVTLHEAHAKIV  116 
             : : :  :::||::::: :| ::::  :: ::  :: : ::::  :|::|:  :|::: : 
EC GSHR      EAIHMYGPDYGFDTTINKFNWETLIASRTAYIDRIHTSYENVLGKNNVDVIKGFARFVDA  119 
 
PM MTLR      GPHEVEVNGERFTAKNILIATGGWPQIPGIPGHEHAIGSNEAFFLKELPKRVLVVGGGYI  176 
             : :|| :: :  ::::|    ::  : ::  :: :: ::::|:: ::: ::| ::| :   
EC GSHR      KTLEVNGETITADHILIATGGRPSHPDIPGVEYGIDSDGFFALPALPERVAVVGAGYIAV  179 
 
PM MTLR      AVEFAGIFHGLGANTTLLYRGDLFLRGFDGSVRKHLQEELTKRGLDLQFNADIARIDKQA  236 
             ::  ::  :| : :::  :: :|  :::::|: :::    ::::|:   ::: :: ::   
EC GSHR      ELAGVINGLGAKTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQLHTNAIPKAVVKNTDG  239 
 
PM MTLR      DGSLKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFIKVDGEYQTTEPSI  296 
             :: |::: ::::    ::: :  ::: : :||:  : :  :::::  :::: : :: ::  
EC GSHR      SLTLELEDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGYIVVDKYQNTNIEGIYA  299 
 
PM MTLR      LALGDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFSLPNIGTVGLSEEE  356 
                ::: ::: :  ||   :: ::::  || ::: :::::   :: :::: : : :::   
EC GSHR      VGDNTGAVELTPVAVAAGRRLSERLFNNKPDEHLDYSNIPTVVFSHPPIGTVGLTEPQAR  359 
 
PM MTLR      ARECGHEVVIFESRFRPMKLTLTDCQEKTLMKLVVDARTDKVLGCHMVGPDAGEIVQGLA  416 
             ::  :::|:   |:|  |:   |:: ::  ||||:: :::|: |:| :|::::| :||:| 
EC GSHR      EQYGDDQVKVYKSSFTAMYTAVTTHRQPCRMKLVCVGSEEKIVGIHGIGFGMDEMLQGFA  419 
 
PM MTLR      IALKAGATKRDFDDTIGVHPTAAEEFVTMRTPVSA  451 
              |||:||||:|||:|  :||||||||||||      
EC GSHR      VALKMGATKKDFDNTVAIHPTAAEEFVTMR-----  449 
 
Alignment of Pseudo Metalloid Reductase Protein Sequence with Yeast GSHR Sequence 
Similarity : 317/447 (70.92 %) 
 
PM MTLR      AYDFDLYVIGAGSGGVRAARFAAGFGAKVAVAESRYLGGTCVNVGCVPKKLLVYGAHFAE  60 
              :::|: ||| |||||: ||:||::|||   :| : ||||||||||||||:::|  ::|: 
SC GSHR      -KHYDYLVIGGGSGGVASARRAASYGAKTLLVEAKALGGTCVNVGCVPKKVMWYASDLAT  59 
 
PM MTLR      DFEQASGFGWNLGEANFDWATLIANKDREINRLNGIYRNLLVNSGVT-LHEAHAKIVGPH  119 
             ::::|: :| ::::  :: : |: |:  :: :::  |:::|::   : | |   ::|::  
SC GSHR      RVSHANEYGLYQNLPLDKEH-LTFNWPEFKQKRDA-YVHRLNGIYQKNL-EKEKVDVVFG  116 
 
PM MTLR      EVEVNGERFTAKNILIATGGWPQIPGIPGHEHAIGSNEAFFLKELPKRVLVVGGGYIAVE  179 
             ::: |::::  : ::::|  ::::: |::::  :   : :::::::: ::::  : :  : 
SC GSHR      WARFNKDGNVEVQKRDNTTEVYSANHILVATGGKAIFPENIPGFELGTDSDGFFRLEEQP  176 
 
PM MTLR      FAGIFHGLGANTTLLYRGDLFLRGFDGSVRKHLQEELTKRGLDLQFNADIARIDKQADGS  239 
             : ::::|:|    :| :: ::|::::  | : :::::: : : :::  |: :: :::: : 
SC GSHR      KKVVVVGAGYIGIELAGVFHGLGSETHLVIRGETVLRKFDECIQNTITDHYVKEGINVHK  236 
 
PM MTLR      LKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFIKVDGEYQTTEPSILAL  299 
             |:  :|: :::| |  : : ::::::|::::: :: ::::: :::: :: :: ::::: : 




PM MTLR      GDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFSLPNIGTVGLSEEEARE  359 
              | : : :: :  : ::::: : |: ::: :::: ::::   ::::|:: : :::::: : 
SC GSHR      ADEYQNTNVPNIYSLGDVVGKVELTPVAIAAGRKLSNRLFGPEKFRNDKLDYENVPSVIF  356 
 
PM MTLR      CGHEVVIFESRFRPMKLTLTDCQEKTLMKLVVDARTDKVLGCHMVGPDAGEIVQGLAIAL  419 
             :  |::::: ::::: ::: : ::| ::::  :: ::  :  :  ::: ::::::: ::: 
SC GSHR      SHPEAGSIGISEKEAIEKYGKENIKVYNSKFTAMYYAMLSEKSPTRYKIVCAGPNEKVVG  416 
 
PM MTLR      KAGATKRDFDDTIGVHPTAAEEFVTMRTPVSA--------------  451 
              : : ::::   :|  :   ::: ::: ::::               
SC GSHR      LHIVGDSSAEILQGFGVAIKMGATKADFDNCVAIHPTSAEELVTMR  462 
 
Alignment of Pseudo Metalloid Reductase Protein Sequence with Human GSHR Protein Sequence 
Similarity : 313/445 (70.34 %) 
 
PM MTLR      --AYDFDLYVI--GAGSGGV--RAARFAAGFGAKVAVA-ESRYL--GGTC-VNVGCVPKK  50 
               | ::|: ||  | |:  :  ||| : |:: ::  :  :: ::  |    ::: : ::: 
HS GSHR      AVA-SYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVH  59 
 
PM MTLR      LLVYGAHFAEDFEQASGFGWNLGEANFDWATLIANKDREINRLNGIYRNLLVNSGVTLHE  110 
             :: : :|::::|::  |: :::::  :::|:::: :: ::|:|::::  ::::: : ::: 
HS GSHR      SEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSD  119 
 
PM MTLR      AHAKIVGPHEVEVNGERF-TAKNI-LI-AT-GGWP-QIPGIPGHEHAIGSNEAFFLK-EL  164 
              : :| :: ::: : : :   ::: :: :     : ::: ::: :  :   : :::  :: 
HS GSHR      PKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGA  179 
 
PM MTLR      PK-RVLVVGGGYIAVEFAGIFHGLGANTTLLYRGDLFLRGFDGSVRKHLQEELTKRGLDL  223 
             :: :|:::|  :: ::: ::: ::: :  ::::  :::  :   :::::::::  ::::: 
HS GSHR      GYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVK  239 
 
PM MTLR      QFNADIARIDKQADGSLKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFI  283 
             ::  :: :::::|: ::   :::  :::   ::   : :: : :|::::|  ::::: :: 
HS GSHR      KTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIV  299 
 
PM MTLR      KVDGEYQTTEPSILALGDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFS  343 
             :   ::: :::::: :: ::   :: : |: :: |::  ::|:::: ::::  ::  ::  
HS GSHR      DEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHP  359 
 
PM MTLR      LPNIGTVGLSEEEARECGHEVVIFESRFRPMKLTLTDCQEKTLMKLVVDARTDKVLGCHM  403 
             :::::   ::|:::::   :|:::: :| ||:: :|: ::| :||:|::::  ||:| || 
HS GSHR      PIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHM  419 
 
PM MTLR      VGPDAGEIVQGLAIALKAGATKRDFDDTIGVHPTAAEEFVTMRTPVSA  451 
              |:: :|: ||:|:|:|:||||:|||:|:  |||  ||:|| |      
HS GSHR      QGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR-----  462 
 
Alignment of Pseudomonas Flourescene GSHR Protein Sequence with E. Coli GSHR Protein Sequence 
Similarity : 304/445 (68.31 %) 
 
PF GSHR      MAYDFDLY-VI-GAGSGGVRAARFAAGFGAKVAVAESRY-LG-GTCVNVGCVPKKLLVYG  56 
               :: | | :| | ::|:::::| |:  :  :::: :::    :::::|: :  :  ::: 
EC GSHR      -TKHYD-YIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPKKVMWHAAQI  58 
 
PF GSHR      AHFAEDFEQSSGFGWNLGEADFDWATLIANKDREINRLNGIYRNLLVNSGVTLHEAHAKI  116 
             :: : :  :::||::::: :: ::::  :: ::  :: : ::::  :|::|:  :|:::  
EC GSHR      REAIHMYGPDYGFDTTINKFNWETLIASRTAYIDRIHTSYENVLGKNNVDVIKGFARFVD  118 
 
PF GSHR      VGPHEVEVNGERYTAKNILIATGGWPQIPEIPGHEHAISSNQAFFLKELPKRVLVVGGGY  176 
114 
 
             :: :|| :: :  ::::|    ::  : ::  :: :: ::::|:: ::: ::| ::| :  
EC GSHR      AKTLEVNGETITADHILIATGGRPSHPDIPGVEYGIDSDGFFALPALPERVAVVGAGYIA  178 
 
PF GSHR      IAVEFAGIFHGLGANTTLLYRGDLFLRGFDGSVRNHLKEELTKRGMDLQFNADIARIDKQ  236 
              ::  ::  :| : :::  :: :|  :::::|: ::::   ::::::   ::: :: ::  
EC GSHR      VELAGVINGLGAKTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQLHTNAIPKAVVKNTD  238 
 
PF GSHR      SDGSLKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFIKVDEQYQTTEPS  296 
             ::: |::: ::::    ::: :  ::: : :||:  : :  :::::  :::: : :: :: 
EC GSHR      GSLTLELEDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGYIVVDKYQNTNIEGIY  298 
 
PF GSHR      ILALGDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFSLPNIGTVGLTEE  356 
                 ::: ::: :  ||   :: ::::  || ::: :::::   :: :::: : : :::  
EC GSHR      AVGDNTGAVELTPVAVAAGRRLSERLFNNKPDEHLDYSNIPTVVFSHPPIGTVGLTEPQA  358 
 
PF GSHR      EAREAGHDVVIYESRFRPMKLTLTDCQERTLMKLVVDGKSDKVLGCHMVGPDAGEIVQGL  416 
              ::  :::|: | |:|  |:   |:: ::  ||||::|:::|: |:| :|::::| :||: 
EC GSHR      REQYGDDQVKVYKSSFTAMYTAVTTHRQPCRMKLVCVGSEEKIVGIHGIGFGMDEMLQGF  418 
 
PF GSHR      AIALKAGATKRDFDDTIGVHPTAAEEFVTMRTPVGA  452 
             | |||:||||:|||:|  :||||||||||||      
EC GSHR      AVALKMGATKKDFDNTVAIHPTAAEEFVTMR-----  449 
 
Alignment of Pseudomonas Flourescene GSHR Protein Sequence with Yeast GSHR Sequence 
Similarity : 327/445 (73.48 %) 
 
PF GSHR      MAYDFDLYVI--GAGSG-GV-RAARFAAGFG-AKVAVAESRYL-GGT-C-VNVGCVPKKL  52 
               :::|: ||  | |:: :: |||:: |::  : : : :: :: :|    ::: :::: : 
SC GSHR      --KHYDYLVIGGGSGGVASARRAASYGAKTLLVEAKALGGTCVNVGCVPKKVMWYASDLA  58 
 
PF GSHR      LVYGAHFAEDFEQSSGFGWNLGEADFDWATLIANKDREI-NRLNGIYRNLLVNSGVTLHE  111 
             ::::::: ::::|:  ::: : : ::   ::::: :::: |::: ::  ::::::| ::: 
SC GSHR      TRVSHANEYGLYQNLPLDKEHLTFNWPEFKQKRDAYVHRLNGIYQKNLEKEKVDVVFGWA  118 
 
PF GSHR      AHAKIVGPHEVEV-N-GERYTAKNI-LIA-TGGW-PQIPEIPGHEHAISSNQAFF-LKEL  165 
             : :|:::: : :: |  |:| |::| ::   :   |::::::  :::::: :::: : :: 
SC GSHR      RFNKDGNVEVQKRDNTTEVYSANHILVATGGKAIFPENIPGFELGTDSDGFFRLEEQPKK  178 
 
PF GSHR      PKRVLVVGGGYIAVEFAGIFHGLGANTTLLYRGDLFLRGFDGSVRNHLKEELTKRGMDLQ  225 
             :::|:::  | : :::  :: :: :   ::  : :::: :  :  :::::::  ::::|: 
SC GSHR      VVVVGAGYIGIELAGVFHGLGSETHLVIRGETVLRKFDECIQNTITDHYVKEGINVHKLS  238 
 
PF GSHR      FNADIARIDKQSDGSLKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFIK  285 
             : ::: ::: ::: ::::::::: ::::   ::  :::: :::: :::|: :::|  ::: 
SC GSHR      KIVKVEKNVETDKLKIHMNDSKSIDDVDELIWTIGRKSHLGMGSENVGIKLNSHDQIIAD  298 
 
PF GSHR      VDEQYQTTEP-SILAL-GDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVF  343 
              :::::  :: |:::: |:|:   :: :: : ::::  : :: :::: :: :: ::  :: 
SC GSHR      EYQNTNVPNIYSLGDVVGKVELTPVAIAAGRKLSNRLFGPEKFRNDKLDYENVPSVIFSH  358 
 
PF GSHR      SLPNIGTVGLTEEEAREAGHDVVIYESRFRPMKLTLTDCQERTLMKLVVDGKSDKVLGCH  403 
              ::::   :::|:: :: : : ::|:|:| :|:: : : :: |::|:|::| : ||:| | 
SC GSHR      PEAGSIGISEKEAIEKYGKENIKVYNSKFTAMYYAMLSEKSPTRYKIVCAGPNEKVVGLH  418 
 
PF GSHR      MVGPDAGEIVQGLAIALKAGATKRDFDDTIGVHPTAAEEFVTMRTPVGA  452 
              ||::  || ||: :|:|:||||:|||: :  ||| |||:||||      





Alignment of Pseudomonas Flourescene GSHR Protein Sequence with Human GSHR Protein Sequence 
Similarity : 315/446 (70.63 %) 
 
PF GSHR      -MAYDFDLYVI--GAGSGGV--RAARFAAGFGAKVAVA-ESRYL--GGTC-VNVGCVPKK  51 
              :| ::|: ||  | |:  :  ||| : |:: ::  :  :: ::  |    ::: : ::: 
HS GSHR      AVA-SYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVH  59 
 
PF GSHR      LLVYGAHFAEDFEQSSGFGWNLGEADFDWATLIANKDREINRLNGIYRNLLVNSGVTLHE  111 
             :: : :|::::|::: |: :::::  :::|:::: :: ::|:|::::  ::::: : ::: 
HS GSHR      SEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSD  119 
 
PF GSHR      AHAKIVGPHEVEVNGER-YTAKN-IL-IA-TG-GWP-QIPEIPGHEHAISSNQAFF-LKE  164 
              : :| :: ::: : :     :: :: ::      : ::::::| :  :   :::: ::: 
HS GSHR      PKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGA  179 
 
PF GSHR      LPKRVLVVGGGYIAVEFAGIFHGLGANTTLLYRGDLFLRGFDGSVRNHLKEELTKRGMDL  224 
             :: :|:::|  :: ::: ::: ::: :  ::::  :::  :   :::::::::  :: :: 
HS GSHR      GYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVK  239 
 
PF GSHR      QFNADIARIDKQSDGSLKATLKDGRVLEADCVFYATGRRPMLDNLGLENIDVQLDDKGFI  284 
             ::  :: ::::: : ::   :::  :::   ::   : :: : :|::::|  ::::: :: 
HS GSHR      KTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIV  299 
 
PF GSHR      KVDEQYQTTEPSILALGDVIGRVQLTPVALAEGMAVARRLFKPEQYRPVDYKMIPTAVFS  344 
             :  :::: :::::: :: ::   :: : |: :: |::  ::|:::: ::::  ::  ::  
HS GSHR      DEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHP  359 
 
PF GSHR      LPNIGTVGLTEEEAREAGHDVVIYESRFRPMKLTLTDCQERTLMKLVVDGKSDKVLGCHM  404 
             :::::   ::|:::::   :|::|: :| ||:: :|: ::: :||:|:::|  ||:| || 
HS GSHR      PIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHM  419 
 
PF GSHR      VGPDAGEIVQGLAIALKAGATKRDFDDTIGVHPTAAEEFVTMRTPVGA  452 
              |:: :|: ||:|:|:|:||||:|||:|:  |||  ||:|| |      
HS GSHR      QGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR-----  462 
 
Alignment of E. Coli GSHR Protein Sequence with Yeast GSHR Sequence 
Similarity : 332/445 (74.61 %) 
 
EC GSHR      TKHYDYIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPKKVMW-------  53 
              |||||::||||||| || :|||:|| | :| ||| |||||||||||||||||        
SC GSHR      -KHYDYLVIGGGSGGVASARRAASYGAKTLLVEAKALGGTCVNVGCVPKKVMWYASDLAT  59 
 
EC GSHR      -----HAAQIREAIHMYGPDYGFDTTINKFNWETLIASRTAYIDRIHTSYENVLGKNNVD  108 
                  :  :: :::  ::::  | :::  : :::::::| : |: ::  :|:|: :: :: 
SC GSHR      RVSHANEYGLYQNLPLDKEHLTF-NWPEFKQKRDAYVHRLNGIYQKNLEKEKVD-VVFGW  117 
 
EC GSHR      VIKGFARFVDAKTLEVN-GETITADH-ILIA-TG-GRPSHPDIP-GVEYGIDSDGFFALP  163 
             :: :::::|  : :::|  | : |:| :::   :   | :: ::  ::::::  ::: :| 
SC GSHR      ARFNKDGNV-EVQKRDNTTEVYSANHILVATGGKAIFPENIPGFELGTDSDGFFRLEEQP  176 
 
EC GSHR      ALPERVAVVGAGYIAVELAGVINGLGAKTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQ  223 
              ::::| ::  | : :::  ::::: :   ::  : :::: : ::: :::::: : :::: 
SC GSHR      KKVVVVGAGYIGIELAGVFHGLGSETHLVIRGETVLRKFDECIQNTITDHYVKEGINVHK  236 
 
EC GSHR      LHTNAIPKAVVKNTDGSLTLELEDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGY  283 
             |:: :::  :| ::: ::::::::: :: :  ::: ::::: :::: ::  : : ::    
SC GSHR      LSKIVKVEKNVETDKLKIHMNDSKSIDDVDELIWTIGRKSHLGMGSENVGIKLNSHDQII  296 
 
EC GSHR      IVVDKYQNTNIEGIYAVGDNTGAVELTPVAVAAGRRLSERLFNNKPDEHLDYSNIPTVVF  343 
             :: : ::|  :: :  ::::::  :: : |: :: :::: :: : ::::||| |:| | | 
116 
 
SC GSHR      ADEYQNTNVPNIYSLGDVVGKVELTPVAIAAGRKLSNRLFGPEKFRNDKLDYENVPSVIF  356 
 
EC GSHR      SHPPIGTVGLTEPQAREQYGDDQVKVYKSSFTAMYTAVTTHRQPCRMKLVCVGSEEKIVG  403 
             |||::|  |: |::| |:||: : |||:|:|||||:|:   ::| |:|:||:| :||:|| 
SC GSHR      SHPEAGSIGISEKEAIEKYGKENIKVYNSKFTAMYYAMLSEKSPTRYKIVCAGPNEKVVG  416 
 
EC GSHR      IHGIGFGMDEMLQGFAVALKMGATKKDFDNTVAIHPTAAEEFVTMR  449 
             :| :|::::| |||| ||:|||||| |||| |||||| |||:|||| 
SC GSHR      LHIVGDSSAEILQGFGVAIKMGATKADFDNCVAIHPTSAEELVTMR  462 
 
Alignment of E. Coli GSHR Protein Sequence with Human GSHR Protein Sequence 
Similarity : 353/447 (78.97 %) 
 
EC GSHR      -TKHYDYIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPKKVMW-HAAQI  58 
                :|||::|||||||:||::|||  |:: |::| ::||||||||||||||||| : |:: 
HS GSHR      AVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNT-AVH  59 
 
EC GSHR      REAIHMYGPDYGFDTTIN-KFNWETLIASRTAYIDRIHTSYENVLGKNNVDVIK-GFARF  116 
             :| :::: :||||   ::  :::: :: ::  ::: :: : :| ::::    ::  :  : 
HS GSHR      SE-FMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTS  118 
 
EC GSHR      VDA-KTLE-VNGETITAD-HI-LI-A-TGGRP-SHPDI-PGVEYG-IDSD--GFFALPAL  165 
             :   : :: ::::|: :   : ::   |   :   ::: :  ::| :      :: :::: 
HS GSHR      DPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVG  178 
 
EC GSHR      PERVAVVGAGYIAVELAGVINGLGAKTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQLH  225 
             ::  ||  || : ::: : :  ::::::|:: ::::: :::: : : :||| : : :::: 
HS GSHR      AGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEV  238 
 
EC GSHR      TNAIPKAVVKNTDGSLTLELEDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGYIV  285 
             :: :::  |:: : :: ::::: : ::||||:|||||:|::::::|:  |  |::||:|  
HS GSHR      KKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHII  298 
 
EC GSHR      VDKYQNTNIEGIYAVGDNTGAVELTPVAVAAGRRLSERLFNNKPDEHLDYSNIPTVVFSH  345 
             ||  ||||::|||||||: | ::||||| ||||:| :||| :|:|::|||:||||||||| 
HS GSHR      VDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSH  358 
 
EC GSHR      PPIGTVGLTEPQAREQYGDDQVKVYKSSFTAMYTAVTTHRQPCRMKLVCVGSEEKIVGIH  405 
             ||||||||||::| ::||  :|| |: ||| ||:|||:::::|:||:||:::|||:|||| 
HS GSHR      PPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIH  418 
 
EC GSHR      GIGFGMDEMLQGFAVALKMGATKKDFDNTVAIHPTAAEEFVTMR  449 
              :|:|:||||||||||:|||||| |||||||||||  ||:|| | 
HS GSHR      MQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR  462 
 
Alignment of Yeast GSHR Sequence with Human GSHR Protein Sequence 
Similarity : 344/454 (75.77 %) 
 
SC GSHR      --KHYDYLVIGGGSGGVASARRAASYGAKTLLVEAKALGGTCVNVGCVPKKVMWYASDLA  58 
                :|||||||||||| |||||||  ||: ::|| : |||||||||||||||||     : 
HS GSHR      AVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMW-----N  55 
 
SC GSHR      TRV-S-HANEYGLYQNLPLDKEHLTFNWPEFKQKRDAYVHRLNGIYQKNLEKEKVDVVFG  116 
             |:| | ::: :  | ::| : |  :|||  :|:||||||:||| |||:|| | ::::: | 
HS GSHR      TAVHSEFMHDHADY-GFP-SCE-GKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRG  112 
 
SC GSHR      WARFNKDGNVEVQKRDNTTEVYSANHILVATGGKAIF-PENI-PGFEL-GTDSD-GFFRL  172 
             :|:|::|::: :::::::: ::::::  :  :::: : :::   : :  : ::: ::::  




SC GSHR      EEQPKKVVVVGAGYIGIELAGVFHGLGSETHLVIRGETVLRKFDECIQNTITDHYVKEGI  232 
                ::::::: ::: ||: |:: :  ::: | : :: :: :: : | :::::: :::::: 
HS GSHR      RSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKF  232 
 
SC GSHR      NVHKLSKIVKVEKNVETDKLKIHMNDSKSIDDVDELIWTIGRKSHLGMGSENVGIKLNSH  292 
             :::|::|  :: ::|  :: :: ::::   ::::  ::: :::::   :: ::::::: : 
HS GSHR      SQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTD  292 
 
SC GSHR      DQIIADEYQNTNVPNIYSLGDVVGKVELTPVAIAAGRKLSNRLFGPEKFRNDKLDYENVP  352 
             |   :: ::::|  :  :  :::: :  :: : |: :: :::  ::|: :::|||| |:| 
HS GSHR      DKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIP  352 
 
SC GSHR      SVIFSHPEAGSIGISEKEAIEKYGKENIKVYNSKFTAMYYAMLSEKSPTRYKIVCAGPNE  412 
              | ||||::|  |: |:||| |||:|| | |: :||:||:|: : |   ::| |||: :| 
HS GSHR      TVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEE  412 
 
SC GSHR      KVVGLHIVGDSSAEILQGFGVAIKMGATKADFDNCVAIHPTSAEELVTMR  462 
             ||||:| :|::::| |||| || ||||||||||| ||||||| |||||:| 
HS GSHR      KVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR  462 
 
Table 5.3.1. Templates used for model generation of GRLMR with homology ranking. 
Homology PDB Enzyme Organism 




2 5V36 Glutathione Reductase Streptococcus mutans 
UA159 
3 2R9Z Glutathione Amide 
Reductase 
Chromatium gracile 
4 3O0H Glutathione Reductase Bartonella henselsea 
5 1GEU Glutathione Reductase 
(Engineered NAD Site) 
Escherichia coli 
6 6B4O Glutathione Reductase Enterococcus faecalis 




8 1TYT Trypanothione 
Reductase 
Crithidia fasciculata 
9 1BWC Glutathione Reductase Homo sapiens 
10 2W0H Trypanothione 
Reductase 
Leishmania infantum 




12 2EQ8 Lipoamide 
Dehydrogenase 
Thermus thermophilus 
13 2V6O Thioredoxin 
Glutathione Reductase 
Schistosoma mansoni 
14 1NDA Trypanothione 
Reductase 
Trypanosoma cruzi 
15 1OJT Dihyrolipoamide 
Dehydrogenase 
Neisseria meningitidis 









18 1XDI Unknown Mycobacterium 
tuberculosis 
19 5X1Y Mercuric Reductase Lysinibacillus sphaericus 




Figure 5.3.2. Product binding pocket for various GSHR’s with key residues highlighted. a: H. sapiens 
(Red- Methionine, Right Teal- Serine, Left Teal- Lysine) b: E. Coli (Red- Methionine, Right Teal- 
Lysine, Left Teal- Lysine) c: S. Cervisiae (Red- Cysteine, Right Teal- Asparagine, Left Teal- Lysine) d: 
P. fluorescines (Red- Serine, Right Teal- Glutamic Acid, Left Teal- Lysine) e: GRLMR (Red- Serine, 
Right Teal- Glutamic Acid, Left Teal- Lysine). 
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Figure 5.3.3. GS-Se-SG  EV-Vis Spectra 








Figure 5.3.5 SEM/EDS overlay of cells exposed to 5mM selenite for 3 hours. a: BL21 E. Coli with a GFP 
reporter plasmid. b: Reporter plasmid cells EDS spectra associated with cells. c: BL21 E. Coli containing 
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